[go: up one dir, main page]

TW201900772A - Hardened film forming composition, alignment material, and phase difference material - Google Patents

Hardened film forming composition, alignment material, and phase difference material Download PDF

Info

Publication number
TW201900772A
TW201900772A TW107110508A TW107110508A TW201900772A TW 201900772 A TW201900772 A TW 201900772A TW 107110508 A TW107110508 A TW 107110508A TW 107110508 A TW107110508 A TW 107110508A TW 201900772 A TW201900772 A TW 201900772A
Authority
TW
Taiwan
Prior art keywords
group
component
forming composition
cured film
alignment
Prior art date
Application number
TW107110508A
Other languages
Chinese (zh)
Other versions
TWI850195B (en
Inventor
伊藤潤
菅野裕太
畑中真
Original Assignee
日商日產化學工業股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商日產化學工業股份有限公司 filed Critical 日商日產化學工業股份有限公司
Publication of TW201900772A publication Critical patent/TW201900772A/en
Application granted granted Critical
Publication of TWI850195B publication Critical patent/TWI850195B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L101/00Compositions of unspecified macromolecular compounds
    • C08L101/02Compositions of unspecified macromolecular compounds characterised by the presence of specified groups, e.g. terminal or pendant functional groups
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D133/00Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Coating compositions based on derivatives of such polymers
    • C09D133/04Homopolymers or copolymers of esters
    • C09D133/14Homopolymers or copolymers of esters of esters containing halogen, nitrogen, sulfur or oxygen atoms in addition to the carboxy oxygen
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D161/00Coating compositions based on condensation polymers of aldehydes or ketones; Coating compositions based on derivatives of such polymers
    • C09D161/20Condensation polymers of aldehydes or ketones with only compounds containing hydrogen attached to nitrogen
    • C09D161/26Condensation polymers of aldehydes or ketones with only compounds containing hydrogen attached to nitrogen of aldehydes with heterocyclic compounds
    • C09D161/28Condensation polymers of aldehydes or ketones with only compounds containing hydrogen attached to nitrogen of aldehydes with heterocyclic compounds with melamine
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B5/00Optical elements other than lenses
    • G02B5/30Polarising elements
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1335Structural association of cells with optical devices, e.g. polarisers or reflectors
    • G02F1/13363Birefringent elements, e.g. for optical compensation
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers

Landscapes

  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Nonlinear Science (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Materials Engineering (AREA)
  • Wood Science & Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mathematical Physics (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Health & Medical Sciences (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polarising Elements (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Paints Or Removers (AREA)

Abstract

To provide a cured film-forming composition for forming a cured film which exhibits excellent liquid crystal alignment properties and light transmissivity when used as an alignment material with a layer of a polymerizable liquid crystal disposed thereupon. A cured film-forming composition containing (A) a polymer having a photodimerization moiety and a self-crosslinking moiety; an alignment material characterized by being obtained using the composition; and a phase difference material characterized by being obtained using the composition.

Description

硬化膜形成組成物、配向材料及相位差材料Hardened film forming composition, alignment material and retardation material

本發明係關於使液晶分子進行配向而成光配向用液晶配向劑的硬化膜形成組成物、由該硬化膜形成組成物所得之配向材料及相位差材料。特別為本發明係關於,使用於圓偏光眼鏡方式的3D顯示上的經製圖之相位差材料,或製造作為有機EL顯示器的反射防止膜使用的圓偏光板上所使用的相位差材料時,成為有用光配向用液晶配向劑的硬化膜形成組成物、由該硬化膜形成組成物所得之配向材料及相位差材料。The present invention relates to a hardened film-forming composition of a liquid crystal alignment agent for photo-alignment by aligning liquid crystal molecules, and an alignment material and a retardation material obtained from the hardened film-forming composition. In particular, the present invention relates to a patterned retardation material used in 3D display of circularly polarized glasses or a retardation material used in the manufacture of a circularly polarizing plate used as an anti-reflection film for an organic EL display. A cured film-forming composition with a liquid crystal alignment agent for photo-alignment, an alignment material and a retardation material obtained from the cured film-forming composition.

圓偏光眼鏡方式之3D顯示時,於形成液晶面板等圖像之顯示元件上通常配置有相位差材料。該相位差材料為,相位差特性相異的2種類相位差區域各以複數個、規則地被配置,構成經製圖的相位差材料。且,以下對於本說明書,欲配置如此相位差特性相異的複數個相位差區域,將經圖型化的相位差材料稱為圖型化相位差材料。In the 3D display of the circularly polarized glasses method, a phase difference material is usually arranged on a display element forming an image such as a liquid crystal panel. This retardation material includes two types of retardation regions having different retardation characteristics, each of which is arranged in a plural number and regularly and constitutes a graphed retardation material. In addition, in the present specification, in order to arrange a plurality of phase difference regions having such different phase difference characteristics, the patterned phase difference material is referred to as a patterned phase difference material.

圖型化相位差材料為,例如如專利文獻1中揭示,可將由聚合性液晶所成的相位差材料作為光學製圖而製作。由聚合性液晶所成的相位差材料之光學製圖可利用在液晶面板之配向材料形成中為已知的光配向技術。即,於基板上設置由光配向性材料所成的塗膜,於此照射偏光方向相異的2種類偏光。而得到作為形成液晶的配向控制方向相異的2種類液晶配向區域之配向材料的光配向膜。於該光配向膜上塗布含有聚合性液晶之溶液狀相位差材料,實現聚合性液晶的配向。其後,將經配向的聚合性液晶進行硬化後形成圖型化相位差材料。The patterned retardation material is, for example, disclosed in Patent Document 1, and a retardation material made of a polymerizable liquid crystal can be produced as an optical pattern. The optical patterning of a retardation material made of a polymerizable liquid crystal can use a photo-alignment technique known in the formation of alignment materials for liquid crystal panels. That is, a coating film made of a photo-alignment material is provided on a substrate, and two types of polarized light having different polarization directions are irradiated there. A light alignment film is obtained as an alignment material for forming two types of liquid crystal alignment regions with different alignment control directions of the liquid crystal. A solution-like retardation material containing a polymerizable liquid crystal is coated on the photo-alignment film to realize the alignment of the polymerizable liquid crystal. Thereafter, the aligned polymerizable liquid crystal is hardened to form a patterned retardation material.

有機EL顯示的反射防止膜係由直線偏光板、1/4波長相位差板所構成,將面向圖像顯示面板的面板面之外來光,藉由直線偏光板使其變換為直線偏光,接著藉由1/4波長相位差板使其變換為圓偏光。其中,藉由該圓偏光之外來光係在圖像顯示面板表面等上反射者,但該反射時會逆轉偏光面之轉動方向。其結果,該反射光與到來時相反,藉由1/4波長相位差板,變換為經直線偏光板被遮光之方向的直線偏光後,繼續藉由直線偏光板使其遮光,其結果對外部之射出顯著地被抑制。The anti-reflection film of the organic EL display is composed of a linear polarizing plate and a 1/4 wavelength retardation plate. The external light facing the panel surface of the image display panel is converted into linear polarized light by a linear polarizing plate. It is converted into circularly polarized light by a 1/4 wavelength retardation plate. Among them, the light outside the circularly polarized light is reflected on the surface of the image display panel or the like, but the direction of rotation of the polarized surface is reversed during the reflection. As a result, the reflected light is opposite to the arrival, and is converted into linearly polarized light in the direction in which the linearly polarizing plate is blocked by a 1/4 wavelength retardation plate, and then continuously blocked by the linearly polarizing plate. The ejection is significantly suppressed.

有關該1/4波長相位差板,如專利文獻2所記載,藉由組合1/2波長板、1/4波長板而構成1/4波長相位差板時,使該光學薄膜藉由逆分散特性構成之方法。該方法之情況時,對於提供於彩色圖像之顯示的較廣波長帶區,使用藉由正分散特性之液晶材料,可構成藉由逆分散特性之光學薄膜。Regarding this 1/4 wavelength retardation plate, as described in Patent Document 2, when a 1/4 wavelength retardation plate is formed by combining a 1/2 wavelength plate and a 1/4 wavelength plate, the optical film is caused to be reversely dispersed. The method of characterization. In the case of this method, for a wide wavelength band provided for display of a color image, a liquid crystal material with a positive dispersion characteristic can be used to constitute an optical film with a reverse dispersion characteristic.

又,近年來,作為可適用於該相位差層之液晶材料,已有人提出具備逆分散特性者(專利文獻3、4)。依據如此逆分散特性之液晶材料,組合1/2波長板、1/4波長板而藉由2層的相位差層構成1/4波長相位差板,反而可使相位差層由單層所構成而確保逆分散特性,藉此可確保對於較廣波長帶區中之所望相位差的光學薄膜可簡易構成而實現。Moreover, in recent years, as a liquid crystal material applicable to this retardation layer, those having reverse dispersion characteristics have been proposed (Patent Documents 3 and 4). Based on the liquid crystal material with such inverse dispersion characteristics, a 1 / 2-wavelength plate and a 1 / 4-wavelength plate are combined to form a 1 / 4-wavelength retardation plate with two retardation layers. Instead, the retardation layer can be composed of a single layer. By ensuring the reverse dispersion characteristics, it is possible to ensure that an optical film with a desired phase difference in a wide wavelength band can be simply constructed and realized.

欲使液晶配向使用配向層。作為配向層之形成方法,例如已知有摩擦法或光配向法,由光配向法中沒有摩擦法的問題點之靜電或灰塵的產生,且可控制定量的配向處理的觀點來看為有用。To align the liquid crystal, an alignment layer is used. As a method for forming the alignment layer, for example, a rubbing method or a photo-alignment method is known, and it is useful from the viewpoint that static electricity or dust can be generated without the problems of the rubbing method in the photo-alignment method and a quantitative alignment process can be controlled.

在使用光配向法之配向材料形成中,作為可利用之光配向性材料,已知有於側鏈上具有肉桂醯基及查爾酮基等光二聚化部位的丙烯酸樹脂或聚醯亞胺樹脂等。有報告指出這些樹脂可藉由進行偏光UV照射,顯示控制液晶的配向之性能(以下亦稱為液晶配向性)(參照專利文獻5~專利文獻7)。In the formation of alignment materials using the photo-alignment method, acrylic resins or polyimide resins having photodimerization sites such as a cinnamonyl group and a chalcone group on a side chain are known as available photo-alignment materials. Wait. It has been reported that these resins can exhibit the performance of controlling the alignment of liquid crystals (hereinafter also referred to as liquid crystal alignment) by performing polarized UV irradiation (see Patent Documents 5 to 7).

又,對於配向層除液晶配向能以外,亦要求耐溶劑性。例如配向層在相位差材料之製造過程中有暴露於熱或溶劑之情況。配向層於溶劑中暴露時,恐怕有液晶配向能顯著降低之疑慮。The alignment layer also requires solvent resistance in addition to the liquid crystal alignment ability. For example, the alignment layer may be exposed to heat or solvents during the manufacturing process of the retardation material. When the alignment layer is exposed to a solvent, there is a concern that the alignment of the liquid crystal can be significantly reduced.

其中,例如專利文獻8中記載,欲得到經安定之液晶配向能,提出含有具有藉由光可交聯反應的結構,與藉由熱進行交聯的結構之聚合物成分之液晶配向劑,及含有具有藉由光可交聯反應的結構之聚合物成分,與具有藉由熱進行交聯的結構之化合物的液晶配向劑。 [先前技術文獻] [專利文獻]Among them, for example, it is described in Patent Document 8 that in order to obtain stable liquid crystal alignment energy, a liquid crystal alignment agent containing a polymer component having a structure that can be crosslinked by photoreaction and a structure that is crosslinked by heat is proposed, and A liquid crystal alignment agent containing a polymer component having a structure that can be crosslinked by light and a compound having a structure that is crosslinked by heat. [Prior Art Literature] [Patent Literature]

[專利文獻1]特開2005-49865號公報   [專利文獻2]特開平10-68816號公報   [專利文獻3]美國專利第8119026號說明書   [專利文獻4]特開2009-179563號公報   [專利文獻5]專利第3611342號公報   [專利文獻6]特開2009-058584號公報   [專利文獻7]特表2001-517719號公報   [專利文獻8]專利第4207430號公報[Patent Document 1] JP 2005-49865 [Patent Document 2] JP 10-68816 [Patent Document 3] US Patent No. 8119026 [Patent Document 4] JP 2009-179563 [Patent Document 5] Patent No. 3611342 [Patent Document 6] JP 2009-058584 [Patent Document 7] Special Table 2001-517719 [Patent Document 8] Patent No. 4207430

[發明所解決的問題][Problems Solved by the Invention]

由以上所示,相位差材料係於配向材料的光配向膜上面,層合經硬化的聚合性液晶之層而構成。因此,必須開發出兼具優良液晶配向性與耐溶劑性之配向材料。As described above, the retardation material is formed on the photo-alignment film of the alignment material, and a layer of a cured polymer liquid crystal is laminated. Therefore, it is necessary to develop an alignment material having both excellent liquid crystal alignment and solvent resistance.

然而,依據本發明者的檢討,得知於側鏈具有肉桂醯基或查爾酮基等光二聚化部位的丙烯酸樹脂在適用於相位差材料的形成時,無法得到充分的特性。特別為對於這些樹脂照射偏光UV而形成配向材料,欲使用該配向材料製作由聚合性液晶所成的相位差材料時,必須大量的偏光UV曝光量。該偏光UV曝光量必須以欲使一般液晶面板用之液晶進行配向之充分偏光UV曝光量(例如30mJ/cm2 程度)更為多。However, according to the review by the inventors, it was found that the acrylic resin having a photodimerization site such as a cinnamonyl group or a chalcone group in a side chain cannot obtain sufficient characteristics when it is suitable for forming a retardation material. In particular, in order to form an alignment material by irradiating polarized UV to these resins, when using this alignment material to produce a retardation material made of a polymerizable liquid crystal, a large amount of polarized UV exposure is required. The amount of polarized UV exposure must be greater than the amount of polarized UV exposure (for example, about 30 mJ / cm 2 ) that is sufficient to align the liquid crystal used for general liquid crystal panels.

作為偏光UV曝光量變多的理由,在相位差材料形成之情況時,與液晶面板用之液晶相異,聚合性液晶在溶液狀態下使用,塗布於配向材料上者。As a reason for increasing the amount of polarized UV exposure, when a retardation material is formed, it is different from the liquid crystal used for a liquid crystal panel, and the polymerizable liquid crystal is used in a solution state and is coated on an alignment material.

使用於側鏈具有肉桂醯基等光二聚化部位的丙烯酸樹脂等而形成配向材料,欲使聚合性液晶進行配向時,對於該丙烯酸樹脂等,進行藉由光二聚化反應之光交聯。而顯現對於聚合性液晶溶液的耐性前,必須進行較多曝光量之偏光照射。欲使液晶面板的液晶進行配向,通常僅將光配向性配向材料的表面進行二聚化反應即可。然而,使用上述丙烯酸樹脂等過去材料,欲於配向材料上表現溶劑耐性時,必須反應至配向材料內部,而必須要有更多量的曝光量。其結果,有著過去材料之配向感度變的非常小之問題產生。An alignment material is formed by using an acrylic resin or the like having a photodimerization site such as a cinnamonyl group in a side chain, and when the polymerizable liquid crystal is to be aligned, the acrylic resin or the like is subjected to photocrosslinking by a photodimerization reaction. On the other hand, before exhibiting resistance to a polymerizable liquid crystal solution, it is necessary to perform polarized light irradiation with a large exposure amount. In order to align the liquid crystal of the liquid crystal panel, usually only the surface of the photo-alignment alignment material is subjected to a dimerization reaction. However, when the conventional materials such as the acrylic resin are used, in order to exhibit solvent resistance on the alignment material, it is necessary to react to the inside of the alignment material, and a larger amount of exposure is required. As a result, there has been a very small problem that the alignment sensitivity of materials has changed in the past.

又,欲於上述過去材料的樹脂上表現如此溶劑耐性時,已知有添加交聯劑的技術。然而,得知進行藉由交聯劑之熱硬化反應後,於所形成的塗膜內部形成3次元結構,會產生光反應性降低。即,會使配向感度大幅度地降低,即使將交聯劑添加於過去材料而使用,亦無法得到所望效果。In order to exhibit such solvent resistance on the resin of the conventional material, a technique of adding a crosslinking agent is known. However, it was found that after performing a thermosetting reaction with a cross-linking agent, a three-dimensional structure was formed inside the formed coating film, and photoreactivity was reduced. That is, the alignment sensitivity is greatly reduced, and even if a crosslinking agent is added to a conventional material and used, the desired effect cannot be obtained.

由以上得知,成為提高配向材料之配向感度,可減低偏光UV曝光量之光配向技術與使用於形成該配向材料之光配向用液晶配向劑的硬化膜形成組成物被期待著。而可高效率地提供相位差材料之技術被期待著。From the above, it is expected that a light alignment technology capable of increasing the alignment sensitivity of the alignment material and reducing the amount of polarized UV exposure and a cured film forming composition for a liquid crystal alignment agent for light alignment for forming the alignment material are expected. A technology that can efficiently provide retardation materials is expected.

本發明之目的係依據以上見解或檢討結果所得者。即,本發明之目的為欲提供一種具有優良耐溶劑性,且在高感度下可使聚合性液晶進行配向的配向材料,進而提供一種成為光配向用液晶配向劑之硬化膜形成組成物。The object of the present invention is based on the above findings or review results. That is, an object of the present invention is to provide an alignment material having excellent solvent resistance and capable of aligning polymerizable liquid crystals under high sensitivity, and further provide a cured film-forming composition that is a liquid crystal alignment agent for photo-alignment.

本發明之其他目的及優點可由以下記載明瞭。 [解決課題的手段]Other objects and advantages of the present invention will be apparent from the following description. [Means for solving problems]

本發明者欲達成上述目的,進行重複的詳細檢討結果,發現藉由選擇將含有(A)具有光二聚化部位及自身交聯部位之聚合物的硬化膜形成組成物作為基礎的硬化膜形成材料,可形成具有優良耐溶劑性且在高感度下可配向聚合性液晶之硬化膜,進而完成本發明。In order to achieve the above object, the present inventors conducted repeated detailed review and found that by selecting a hardened film forming material containing a hardened film forming composition containing a polymer having a photodimerization site and a self-crosslinking site as a base, A hardened film having excellent solvent resistance and capable of orienting a polymerizable liquid crystal under high sensitivity can be formed, thereby completing the present invention.

即,作為本發明的第1觀點,其係關於含有(A)具有光二聚化部位及自身交聯部位的聚合物之硬化膜形成組成物。   作為第2觀點,其係關於(A)成分的自身交聯部位為羥甲基或烷氧基甲基的第1觀點所記載的硬化膜形成組成物。   作為第3觀點,其係關於進一步含有(B)具有2個以上選自由羥甲基、烷氧基甲基、羥基、羧基、醯胺基、胺基及烷氧基矽基所成群的至少1個基之單體或者聚合物的第1觀點或第2觀點所記載的硬化膜形成組成物。   作為第4觀點,其係關於進一步含有(C)交聯觸媒之第1觀點至第3觀點中任一所記載的硬化膜形成組成物。   作為第5觀點,其係關於含有(D)具有1個以上的聚合性基、與選自由羥基、羧基、醯胺基、胺基及烷氧基矽基所成群的至少1個基A,或與該基A進行反應的至少1個基之化合物的第1觀點至第4觀點中任一所記載的硬化膜形成組成物。   作為第6觀點,其係關於對於(A)成分100質量份而言,含有1質量份~400質量份的(B)成分之第3觀點至第5觀點中任一所記載的硬化膜形成組成物。   作為第7觀點,其係關於對於(A)成分100質量份而言,含有0.01質量份~20質量份的(C)成分之第4觀點至第6觀點中任一所記載的硬化膜形成組成物。   作為第8觀點,其係關於對於(A)成分100質量份而言,含有1質量份~100質量份的(D)成分之第5觀點至第7觀點中任一所記載的硬化膜形成組成物。   作為第9觀點,係關於以硬化第1觀點至第8觀點中任一所記載的硬化膜形成組成物而得者為特徵之硬化膜。   作為第10觀點,係關於以硬化第1觀點至第8觀點中任一所記載的硬化膜形成組成物而得者為特徵之配向材料。   作為第11觀點,係關於以使用由第1觀點至第8觀點中任一所記載的硬化膜形成組成物所得之硬化膜而形成者為特徵之相位差材料。 [發明之效果]That is, as a first aspect of the present invention, it relates to a cured film-forming composition containing (A) a polymer having a photodimerization site and a self-crosslinking site. (2) As a second viewpoint, the cured film forming composition according to the first viewpoint is that the self-crosslinking site of the component (A) is methylol or alkoxymethyl. As a third aspect, it is further about (B) having at least two groups selected from the group consisting of methylol, alkoxymethyl, hydroxyl, carboxyl, amido, amine, and alkoxysilyl groups. The cured film forming composition according to the first or second aspect of the monomer or polymer of one group. As a fourth aspect, the cured film-forming composition according to any one of the first to third aspects further containing (C) a cross-linking catalyst. As a fifth aspect, it is about (D) containing at least one polymerizable group having at least one group A selected from the group consisting of a hydroxyl group, a carboxyl group, a amine group, an amine group, and an alkoxysilyl group, The cured film forming composition according to any one of the first to fourth aspects of the compound of at least one group that reacts with the group A. The 6th viewpoint is the hardening film formation composition as described in any one of the 3rd viewpoint-5th viewpoint which contains 1 mass part-400 mass parts of (B) component with respect to 100 mass parts of (A) component. Thing. The seventh aspect is the cured film forming composition according to any one of the fourth aspect to the sixth aspect with respect to 100 parts by mass of the (A) component and containing 0.01 to 20 parts by mass of the (C) component. Thing. The eighth aspect is the cured film forming composition described in any one of the fifth to seventh aspects with respect to 100 parts by mass of the (A) component and containing 1 to 100 parts by mass of the (D) component. Thing. As a ninth aspect, the cured film is characterized by being obtained by curing the cured film-forming composition described in any one of the first to eighth aspects. As a tenth aspect, it is an alignment material characterized by being obtained by curing the cured film-forming composition described in any one of the first to eighth aspects. As an eleventh aspect, the present invention relates to a retardation material characterized by being formed using a cured film obtained by using the cured film-forming composition described in any one of the first to eighth aspects. [Effect of the invention]

依據本發明可提供一種具有優良耐溶劑性,在高感度可使聚合性液晶進行配向的硬化膜,與適用於該形成之硬化膜形成組成物。   依據本發明可提供具有優良液晶配向性與光透過性之配向材料,及可達到高精度光學製圖之相位差材料。According to the present invention, it is possible to provide a cured film having excellent solvent resistance and capable of aligning polymerizable liquid crystals at a high sensitivity, and a cured film forming composition suitable for the formation. According to the present invention, an alignment material having excellent liquid crystal alignment and light transmittance, and a phase difference material capable of achieving high-precision optical mapping can be provided.

<硬化膜形成組成物>   本發明之硬化膜形成組成物為含有(A)具有光二聚化部位及自身交聯部位之聚合物。本發明之硬化膜形成組成物除上述(A)成分以外,可進一步含有作為(B)成分的具有2個以上選自由羥甲基、烷氧基甲基、羥基、羧基、醯胺基、胺基及烷氧基矽基所成群的至少1個基之單體或者聚合物者。亦進一步可含有作為(C)成分的交聯觸媒者。進一步可含有作為(D)成分的具有1個以上的聚合性基,與選自由羥基、羧基、醯胺基、胺基及烷氧基矽基所成群的至少1個基A,或與該基A進行反應的至少1個基之化合物。而不損害本發明之效果下,可含有其他添加劑。   以下詳細說明各成分。<Hard film-forming composition> 硬化 The hard film-forming composition of the present invention contains (A) a polymer having a photodimerization site and a self-crosslinking site. The cured film forming composition of the present invention may further contain, as the component (B), two or more members selected from the group consisting of methylol, alkoxymethyl, hydroxyl, carboxyl, amine, and amine, in addition to the component (A). A monomer or polymer having at least one group formed by a group and an alkoxysilyl group. It may further contain a crosslinking catalyst as a component (C). It may further contain one or more polymerizable groups as the component (D), and at least one group A selected from the group consisting of a hydroxyl group, a carboxyl group, an amido group, an amino group, and an alkoxysilyl group, or A compound in which at least one group of groups A reacts. Without impairing the effect of the present invention, other additives may be contained.成分 Each component is explained in detail below.

<(A)成分>   (A)成分為具有光二聚化部位及自身交聯部位之丙烯酸共聚物。   本發明中,作為丙烯酸共聚物,可使用聚合具有丙烯酸酯、甲基丙烯酸酯、苯乙烯等不飽和雙鍵之單體而得的共聚物。<(A) component> (A) component is an acrylic copolymer which has a photodimerization site | part and a self-crosslinking site | part.中 In the present invention, as the acrylic copolymer, a copolymer obtained by polymerizing a monomer having an unsaturated double bond such as acrylate, methacrylate, or styrene can be used.

(A)成分的具有光二聚化部位及自身交聯部位之丙烯酸共聚物(以下亦稱為特定共聚物)若為具有該結構之丙烯酸共聚物即可,對於構成丙烯酸共聚物的高分子之主鏈的骨架及側鏈之種類等並無特別限定。The acrylic copolymer of the component (A) having a photodimerization site and a self-crosslinking site (hereinafter also referred to as a specific copolymer) may be an acrylic copolymer having such a structure. The type of the skeleton and side chains of the chain are not particularly limited.

所謂光二聚化部位為藉由光照射而形成二聚物的部位,作為該具體例子,可舉出肉桂醯基、查爾酮基、香豆素基、蒽基等。這些中,以具有在可見光區域的高透明性及光二聚化反應性之肉桂醯基為佳。較佳的肉桂醯基之結構如下述式[1]或式[2]所示。上述式中,X1 表示氫原子、碳原子數1至18的烷基、苯基或聯苯基。此時,苯基及聯苯基可由鹵素原子、烷基、烷氧基及氰基中任一者進行取代。X2 表示氫原子、氰基、碳原子數1至18的烷基、苯基、聯苯基或環己基。此時,碳原子數1至18的烷基、苯基、聯苯基、環己基可介著單鍵、醚鍵、酯鍵、醯胺鍵、尿素鍵與苯環鍵結。The photodimerization site is a site that forms a dimer upon irradiation with light. Specific examples of the site include a cinnamyl group, a chalcone group, a coumarin group, and an anthracenyl group. Among these, a cinnamyl group having high transparency in the visible light region and photodimerization reactivity is preferred. The structure of a preferable cinnamyl group is shown by the following formula [1] or [2]. In the above formula, X 1 represents a hydrogen atom, an alkyl group having 1 to 18 carbon atoms, a phenyl group, or a biphenyl group. In this case, phenyl and biphenyl may be substituted with any one of a halogen atom, an alkyl group, an alkoxy group, and a cyano group. X 2 represents a hydrogen atom, a cyano group, an alkyl group having 1 to 18 carbon atoms, a phenyl group, a biphenyl group, or a cyclohexyl group. At this time, the alkyl group, phenyl group, biphenyl group, and cyclohexyl group having 1 to 18 carbon atoms may be bonded to a benzene ring via a single bond, an ether bond, an ester bond, a amide bond, a urea bond, or the like.

所謂自身交聯部位為,彼此鍵結形成交聯結構的部位,可舉出烷氧基甲基醯胺基、羥基甲基醯胺基、烷氧基矽基及封閉型異氰酸酯基等。The self-crosslinking site is a site that is bonded to each other to form a crosslinked structure, and examples thereof include an alkoxymethylamidino group, a hydroxymethylamidino group, an alkoxysilyl group, and a blocked isocyanate group.

(A)成分的丙烯酸共聚物之重量平均分子量以3,000至200,000者為佳,以4,000至150,000者為較佳,以5,000至100,000者為更佳。若重量平均分子量為超過200,000的過大者時,對於溶劑之溶解性會降低且處理性亦會降低的情況會產生,重量平均分子量若未達3,000之過小者時,於熱硬化時的硬化會變的不足,且溶劑耐性及耐熱性會降低的情況會產生。The weight average molecular weight of the acrylic copolymer (A) is preferably 3,000 to 200,000, more preferably 4,000 to 150,000, and even more preferably 5,000 to 100,000. If the weight average molecular weight is more than 200,000, the solubility to the solvent will be reduced, and the handleability will also decrease. If the weight average molecular weight is less than 3,000, the hardening during thermal curing will be changed. Insufficient and solvent resistance and heat resistance may be reduced.

如上述,作為(A)成分的於側鏈具有光二聚化部位及自身交聯部位之丙烯酸共聚物的合成方法,以將具有光二聚化部位的單體,與具有自身交聯性基之單體進行共聚合的方法為簡便。As described above, as the component (A), a method for synthesizing an acrylic copolymer having a photodimerization site and a self-crosslinking site in a side chain is used to separate a monomer having a photodimerization site with a monomer having a self-crosslinkable group. The method of copolymerization of the polymer is simple.

作為具有光二聚化部位的單體,例如可舉出具有肉桂醯基、查爾酮基、香豆素基或蒽基等單體。這些中以具有在可見光區域的透明性及光二聚化反應性為良好的肉桂醯基之單體為特佳。Examples of the monomer having a photodimerization site include monomers having a cinnamyl group, a chalcone group, a coumarin group, or an anthracene group. Among these, a monomer having a cinnamyl group having good transparency and photodimerization reactivity in the visible light region is particularly preferred.

特別以具有上述式[1]或式[2]所示結構之肉桂醯基的單體為較佳。如此單體的具體例子如下述式[3]或式[4]所示。前述式中,X1 表示氫原子、碳原子數1至18的烷基、苯基或聯苯基。此時,苯基及聯苯基可由鹵素原子、烷基、烷氧基及氰基中任一者所取代。X2 表示氫原子、氰基、碳原子數1至18的烷基、苯基、聯苯基或環己基。此時,碳原子數1至18的烷基、苯基、聯苯基及環己基可介著單鍵、醚鍵、酯鍵、醯胺鍵或尿素鍵與苯環鍵結。X3 及X5 各獨立表示單鍵、碳原子數1至20的伸烷基、芳香族環基或脂肪族環基。其中碳原子數1至20的伸烷基可為支鏈狀亦可為直鏈狀,亦可由羥基所取代,亦可藉由選自醚鍵、酯鍵、醯胺鍵、尿素鍵及胺基甲酸酯鍵的至少一種鍵結進行中斷。X4 及X6 表示聚合性基。作為該聚合性基之具體例子,例如可舉出丙烯醯基、甲基丙烯醯基、苯乙烯基、馬來醯亞胺基、丙烯醯胺基及甲基丙烯醯胺基等。In particular, a cinnamylmer group having a structure represented by the formula [1] or the formula [2] is preferred. Specific examples of such monomers are shown in the following formula [3] or formula [4]. In the foregoing formula, X 1 represents a hydrogen atom, an alkyl group having 1 to 18 carbon atoms, a phenyl group, or a biphenyl group. In this case, phenyl and biphenyl may be substituted with any one of a halogen atom, an alkyl group, an alkoxy group, and a cyano group. X 2 represents a hydrogen atom, a cyano group, an alkyl group having 1 to 18 carbon atoms, a phenyl group, a biphenyl group, or a cyclohexyl group. At this time, the alkyl group, phenyl group, biphenyl group, and cyclohexyl group having 1 to 18 carbon atoms may be bonded to the benzene ring via a single bond, an ether bond, an ester bond, a amide bond, or a urea bond. X 3 and X 5 each independently represent a single bond, an alkylene group having 1 to 20 carbon atoms, an aromatic ring group, or an aliphatic ring group. The alkylene group having 1 to 20 carbon atoms may be branched or linear, or may be substituted by a hydroxyl group, or may be selected from an ether bond, an ester bond, a amine bond, a urea bond, and an amine group. At least one bond of the formate bond is interrupted. X 4 and X 6 represent polymerizable groups. Specific examples of the polymerizable group include acrylfluorenyl, methacrylfluorenyl, styryl, maleimide, acrylamido, and methacrylamido.

作為具有自身交聯部位之單體,例如可舉出N-羥基甲基(甲基)丙烯醯胺、N-甲氧基甲基(甲基)丙烯醯胺、N-乙氧基甲基(甲基)丙烯醯胺、N-丁氧基甲基(甲基)丙烯醯胺等由羥基甲基或烷氧基甲基所取代的(甲基)丙烯醯胺化合物;3-三甲氧基矽基丙基丙烯酸酯、3-三乙氧基矽基丙基丙烯酸酯、3-三甲氧基矽基丙基甲基丙烯酸酯、3-三乙氧基矽基丙基甲基丙烯酸酯等具有烷氧基矽基的單體;具有甲基丙烯酸2-(0-(1’-甲基亞丙基胺基)羧基胺基)乙基、甲基丙烯酸2-(3,5-二甲基吡唑基)羰基胺基)乙基等封閉型異氰酸酯基之單體等。且所謂(甲基)丙烯醯胺表示丙烯醯胺與甲基丙烯醯胺之雙方。Examples of the monomer having a self-crosslinking site include N-hydroxymethyl (meth) acrylamide, N-methoxymethyl (meth) acrylamide, and N-ethoxymethyl ( (Meth) acrylamide, N-butoxymethyl (meth) acrylamide, etc. (meth) acrylamide compounds substituted with hydroxymethyl or alkoxymethyl; 3-trimethoxysilyl Propyl acrylate, 3-triethoxysilylpropylacrylate, 3-trimethoxysilylpropylmethacrylate, 3-triethoxysilylpropylmethacrylate, etc. Monooxysilane-based monomer; 2- (0- (1'-methylpropyleneamino) carboxyamino) ethyl methacrylate, 2- (3,5-dimethylpyridine) A blocked isocyanate-based monomer such as oxazolyl) carbonylamino) ethyl and the like. The (meth) acrylamide refers to both acrylamide and methacrylamide.

又,對於本發明,若要得到特定共聚物時,於具有光二聚化部位及自身交聯部位(以下亦稱為特定官能基)之單體以外,可併用該單體與可共聚合之單體。In addition, in the present invention, in order to obtain a specific copolymer, in addition to a monomer having a photodimerization site and a self-crosslinking site (hereinafter also referred to as a specific functional group), the monomer may be used in combination with a copolymerizable monomer body.

作為如此單體之具體例子,可舉出丙烯酸酯化合物、甲基丙烯酸酯化合物、馬來醯亞胺化合物、丙烯醯胺化合物、丙烯腈、馬來酸酐、苯乙烯化合物及乙烯基化合物等。Specific examples of such a monomer include an acrylate compound, a methacrylate compound, a maleimide compound, an acrylamide compound, acrylonitrile, maleic anhydride, a styrene compound, and a vinyl compound.

以下舉出前述單體之具體例子,但並未限定於此等。   作為前述丙烯酸酯化合物,例如可舉出甲基丙烯酸酯、乙基丙烯酸酯、2-羥基乙基丙烯酸酯、2-羥基丙基丙烯酸酯、4-羥基丁基丙烯酸酯、2,3-二羥基丙基丙烯酸酯、二乙二醇單丙烯酸酯、己內酯2-(丙烯醯氧基)乙基酯、聚(乙二醇)乙基醚丙烯酸酯、5-丙烯醯氧基-6-羥基降冰片烯-2-羧基-6-內酯、丙烯酸、單-(2-(丙烯醯氧基)乙基)鄰苯二甲酸酯、縮水甘油基丙烯酸酯、異丙基丙烯酸酯、苯甲基丙烯酸酯、萘丙烯酸酯、蒽基丙烯酸酯、蒽基甲基丙烯酸酯、苯基丙烯酸酯、2,2,2-三氟乙基丙烯酸酯、tert-丁基丙烯酸酯、環己基丙烯酸酯、異冰片基丙烯酸酯、2-甲氧基乙基丙烯酸酯、甲氧基三乙二醇丙烯酸酯、2-乙氧基乙基丙烯酸酯、2-胺基乙基丙烯酸酯、四氫糠基丙烯酸酯、3-甲氧基丁基丙烯酸酯、2-甲基-2-金剛烷基丙烯酸酯、2-丙基-2-金剛烷基丙烯酸酯、8-甲基-8-三環癸基丙烯酸酯及8-乙基-8-三環癸基丙烯酸酯等。Specific examples of the aforementioned monomers are given below, but are not limited thereto. Examples of the acrylate compound include methacrylate, ethacrylate, 2-hydroxyethyl acrylate, 2-hydroxypropyl acrylate, 4-hydroxybutyl acrylate, and 2,3-dihydroxy. Propyl acrylate, diethylene glycol monoacrylate, caprolactone 2- (propenyloxy) ethyl ester, poly (ethylene glycol) ethyl ether acrylate, 5-propenyloxy-6-hydroxyl Norbornene-2-carboxy-6-lactone, acrylic acid, mono- (2- (propenyloxy) ethyl) phthalate, glycidyl acrylate, isopropyl acrylate, benzoic acid Acrylate, naphthalene acrylate, anthryl acrylate, anthryl methacrylate, phenyl acrylate, 2,2,2-trifluoroethyl acrylate, tert-butyl acrylate, cyclohexyl acrylate, Isobornyl acrylate, 2-methoxyethyl acrylate, methoxytriethylene glycol acrylate, 2-ethoxyethyl acrylate, 2-aminoethyl acrylate, tetrahydrofurfuryl acrylate Ester, 3-methoxybutyl acrylate, 2-methyl-2-adamantyl acrylate, 2-propyl-2-adamantyl acrylate, 8-methyl-8 -Tricyclodecyl acrylate and 8-ethyl-8-tricyclodecyl acrylate.

作為前述甲基丙烯酸酯化合物,例如可舉出甲基甲基丙烯酸酯、乙基甲基丙烯酸酯、2-羥基乙基甲基丙烯酸酯、2-羥基丙基甲基丙烯酸酯、4-羥基丁基甲基丙烯酸酯、2,3-二羥基丙基甲基丙烯酸酯、二乙二醇單甲基丙烯酸酯、己內酯2-(甲基丙烯醯氧)乙基酯、5-甲基丙烯醯氧-6-羥基降冰片烯-2-羧基-6-內酯、縮水甘油基甲基丙烯酸酯、異丙基甲基丙烯酸酯、苯甲基甲基丙烯酸酯、萘甲基丙烯酸酯、蒽基甲基丙烯酸酯、蒽基甲基甲基丙烯酸酯、苯基甲基丙烯酸酯、2,2,2-三氟乙基甲基丙烯酸酯、tert-丁基甲基丙烯酸酯、環己基甲基丙烯酸酯、異冰片基甲基丙烯酸酯、2-甲氧基乙基甲基丙烯酸酯、甲氧基三乙二醇甲基丙烯酸酯、2-乙氧基乙基甲基丙烯酸酯、2-胺基甲基甲基丙烯酸酯、四氫糠基甲基丙烯酸酯、3-甲氧基丁基甲基丙烯酸酯、2-甲基-2-金剛烷基甲基丙烯酸酯、γ-丁內酯甲基丙烯酸酯、2-丙基-2-金剛烷基甲基丙烯酸酯、8-甲基-8-三環癸基甲基丙烯酸酯及8-乙基-8-三環癸基甲基丙烯酸酯等。Examples of the methacrylate compound include methmethacrylate, ethylmethacrylate, 2-hydroxyethylmethacrylate, 2-hydroxypropylmethacrylate, and 4-hydroxybutyl methyl ester. Acrylate, 2,3-dihydroxypropyl methacrylate, diethylene glycol monomethacrylate, caprolactone 2- (methacrylic acid) ethyl ester, 5-methacrylic acid -6-hydroxynorbornene-2-carboxy-6-lactone, glycidyl methacrylate, isopropyl methacrylate, benzyl methacrylate, naphthalene methacrylate, anthracene methyl Acrylate, anthryl methacrylate, phenyl methacrylate, 2,2,2-trifluoroethyl methacrylate, tert-butyl methacrylate, cyclohexyl methacrylate, isopropyl Bornyl methacrylate, 2-methoxyethyl methacrylate, methoxytriethylene glycol methacrylate, 2-ethoxyethyl methacrylate, 2-aminomethyl methyl Acrylate, tetrahydrofurfuryl methacrylate, 3-methoxybutyl methacrylate, 2-methyl-2-adamantyl methacrylate Ester, γ-butyrolactone methacrylate, 2-propyl-2-adamantyl methacrylate, 8-methyl-8-tricyclodecyl methacrylate, and 8-ethyl-8- Tricyclodecyl methacrylate and the like.

作為前述丙烯醯胺化合物,例如可舉出丙烯醯胺、甲基丙烯醯胺、N-(羧基苯基)甲基丙烯醯胺、N-(羧基苯基)丙烯醯胺、N-(羥基苯基)甲基丙烯醯胺及N-(羥基苯基)丙烯醯胺等。Examples of the acrylamide compound include acrylamide, methacrylamide, N- (carboxyphenyl) methacrylamide, N- (carboxyphenyl) acrylamide, and N- (hydroxybenzene Methacrylamide and N- (hydroxyphenyl) acrylamide.

作為前述乙烯基化合物,例如可舉出甲基乙烯基醚、苯甲基乙烯基醚、乙烯基萘、乙烯基咔唑、烯丙基縮水甘油基醚、3-乙烯基-7-氧雜聯環[4.1.0]庚烷、1,2-環氧-5-己烯及1,7-辛二烯單環氧化物等。Examples of the vinyl compound include methyl vinyl ether, benzyl vinyl ether, vinyl naphthalene, vinyl carbazole, allyl glycidyl ether, and 3-vinyl-7-oxo Cyclo [4.1.0] heptane, 1,2-epoxy-5-hexene and 1,7-octadiene monoepoxide, etc.

作為前述苯乙烯化合物,例如可舉出苯乙烯、甲基苯乙烯、氯苯乙烯、溴苯乙烯等。Examples of the styrene compound include styrene, methylstyrene, chlorostyrene, and bromostyrene.

作為前述馬來醯亞胺化合物,例如可舉出馬來醯亞胺、N-甲基馬來醯亞胺、N-苯基馬來醯亞胺、N-(羥基苯基)馬來醯亞胺、N-(羧基苯基)馬來醯亞胺及N-環己基馬來醯亞胺等。Examples of the maleimide compound include maleimide, N-methylmaleimide, N-phenylmaleimide, and N- (hydroxyphenyl) maleimide , N- (carboxyphenyl) maleimide and N-cyclohexylmaleimide and the like.

欲得到特定聚合物而使用的各單體之使用量係以全單體合計量為基準,具有25至90莫耳%的光二聚化部位的單體,具有10至75莫耳%之自身交聯部位的單體,以不具有0至65莫耳%之特定官能基的單體為佳。具有光二聚化部位的單體之含有量若比25莫耳%少時,難以賦予高感度且良好液晶配向性。具有自身交聯部位之單體的含有量若比10莫耳%少時,難以賦予充分熱硬化性,且難維持高感度與良好液晶配向性。The amount of each monomer used to obtain a specific polymer is based on the total amount of all monomers, a monomer having a photodimerization site of 25 to 90 mole%, and a self-crosslinking of 10 to 75 mole%. The monomer of the linking site is preferably a monomer having no specific functional group of 0 to 65 mole%. When the content of the monomer having a photodimerization site is less than 25 mol%, it is difficult to provide high sensitivity and good liquid crystal alignment. When the content of the monomer having a self-crosslinking portion is less than 10 mol%, it is difficult to impart sufficient thermosetting properties, and it is difficult to maintain high sensitivity and good liquid crystal alignment.

欲得到使用於本發明的特定共聚物之方法並無特別限定,例如於具有特定官能基之單體與視所需不具有特定官能基之單體與聚合起始劑等共存之溶劑中,在50至110℃之溫度下藉由聚合反應而得。此時,所使用的溶劑為可溶解具有特定官能基之單體、視所需而使用的不具有特定官能基之單體及聚合起始劑等者即可,並無特別限定。作為具體例子如後述之<溶劑>所記載。   藉由前述方法所得之特定共聚物,通常為溶解於溶劑之溶液狀態。The method for obtaining the specific copolymer used in the present invention is not particularly limited. For example, in a solvent in which a monomer having a specific functional group and a monomer having no specific functional group as required and a polymerization initiator coexist, It is obtained by polymerization at a temperature of 50 to 110 ° C. In this case, the solvent to be used is not particularly limited as long as it can dissolve a monomer having a specific functional group, a monomer having no specific functional group, a polymerization initiator, etc., if necessary. A specific example is described in <solvent> mentioned later.特定 The specific copolymer obtained by the aforementioned method is usually in a solution state dissolved in a solvent.

又,將由上述方法所得之特定共聚物的溶液投入於攪拌下的二乙基醚或水等使其再沈澱,將生成的沈澱物經過濾・洗淨後,在常壓或減壓下,進行常溫乾燥或加熱乾燥,可使其成為特定共聚物之粉體。藉由前述操作,可除去與特定共聚物共存的聚合起始劑及未反應之單體,其結果,得到經純化的特定共聚物之粉體。若在一次操作無法充分地純化時,可將所得之粉體於溶劑中再溶解,並重複進行上述操作即可。In addition, the solution of the specific copolymer obtained by the above method is re-precipitated by adding diethyl ether or water under stirring, and the resulting precipitate is filtered and washed, and then the solution is subjected to normal pressure or reduced pressure. Drying at room temperature or drying under heat can make it a powder of specific copolymer. By the foregoing operation, the polymerization initiator and unreacted monomers that coexist with the specific copolymer can be removed, and as a result, a powder of the purified specific copolymer can be obtained. If sufficient purification cannot be performed in one operation, the obtained powder may be redissolved in a solvent, and the above operations may be repeated.

對於本發明,特定共聚物可於粉體形態,或者將經純化的粉末再溶解於後述溶劑的溶液形態下使用。In the present invention, the specific copolymer can be used in the form of a powder or a solution in which the purified powder is redissolved in a solvent described later.

又,對於本發明,(A)成分之特定共聚物可為複數種特定共聚物之混合物。In the present invention, the specific copolymer of the component (A) may be a mixture of a plurality of specific copolymers.

<(B)成分>   本發明之硬化膜形成組成物中,作為(B)成分,可含有具有2個以上選自由羥甲基、烷氧基甲基、羥基、羧基、醯胺基、胺基及烷氧基矽基所成群的至少1的基之單體或者聚合物。<(B) component> 硬化 The hardened film forming composition of the present invention may contain, as component (B), two or more members selected from the group consisting of methylol, alkoxymethyl, hydroxyl, carboxyl, amido, and amino groups. A monomer or polymer having at least one group of alkoxysilyl groups.

作為具有2個以上羥甲基、烷氧基甲基之單體或者聚合物,例如可舉出烷氧基甲基化乙二醇脲、烷氧基甲基化苯並胍胺及烷氧基甲基化三聚氰胺等羥甲基化合物。Examples of the monomer or polymer having two or more methylol groups and alkoxymethyl groups include alkoxymethylated ethylene glycol urea, alkoxymethylated benzoguanamine, and alkoxy groups. Methylated methylol compounds such as melamine.

作為烷氧基甲基化乙二醇脲之具體例子,例如可舉出1,3,4,6-肆(甲氧基甲基)乙二醇脲、1,3,4,6-肆(丁氧基甲基)乙二醇脲、1,3,4,6-肆(羥基甲基)乙二醇脲、1,3-雙(羥基甲基)尿素、1,1,3,3-肆(丁氧基甲基)尿素、1,1,3,3-肆(甲氧基甲基)尿素、1,3-雙(羥基甲基)-4,5-二羥基-2-咪唑啉酮,及1,3-雙(甲氧基甲基)-4,5-二甲氧基-2-咪唑啉酮等。作為市售品,可舉出Japan Cytec Industries(股) (Former Mitsui Cytec(股))製乙二醇脲化合物(商品名:Cymel(註冊商標)1170、Powder link(註冊商標)1174)等化合物、甲基化尿素樹脂(商品名:UFR(註冊商標)65)、丁基化尿素樹脂(商品名:UFR(註冊商標)300、U-VAN10S60、U-VAN10R、U-VAN11HV)、DIC(股)(原大日本油墨化學工業(股))製尿素/甲醛系樹脂(高縮合型、商品名:Beccamine(註冊商標)J-300S、同P-955、同N)等。Specific examples of the alkoxymethylated glycol urea include 1,3,4,6- (methoxymethyl) glycol urea, 1,3,4,6- ( Butoxymethyl) glycol urea, 1,3,4,6- (Hydroxymethyl) glycol urea, 1,3-bis (hydroxymethyl) urea, 1,1,3,3- Silyl (butoxymethyl) urea, 1,1,3,3-silyl (methoxymethyl) urea, 1,3-bis (hydroxymethyl) -4,5-dihydroxy-2-imidazoline Ketones, and 1,3-bis (methoxymethyl) -4,5-dimethoxy-2-imidazolinones. Examples of commercially available products include compounds such as ethylene glycol urea compounds (trade names: Cymel (registered trademark) 1170, Powder link (registered trademark) 1174) made by Japan Cytec Industries (former Mitsui Cytec (stock)), Methylated urea resin (trade name: UFR (registered trademark) 65), butylated urea resin (trade name: UFR (registered trademark) 300, U-VAN10S60, U-VAN10R, U-VAN11HV), DIC (stock) (Formerly Dainippon Ink Chemical Industry Co., Ltd.) made of urea / formaldehyde resin (high condensation type, trade name: Beccamine (registered trademark) J-300S, same as P-955, same as N), etc.

作為烷氧基甲基化苯並胍胺之具體例子,可舉出四甲氧基甲基苯並胍胺等。作為市售品,可舉出Japan Cytec Industries(股)(Former Mitsui Cytec(股))製(商品名:Cymel(註冊商標)1123)、(股)三和化學製(商品名:Nicarac(註冊商標)BX-4000、同BX-37、同BL-60、同BX-55H)等。Specific examples of the alkoxymethylated benzoguanamine include tetramethoxymethylbenzoguanamine and the like. Examples of commercially available products include Japan Cytec Industries (former Mitsui Cytec (stock)) (trade name: Cymel (registered trademark) 1123), (share) Sanwa Chemical (trade name: Nicarac (registered trademark) ) BX-4000, same as BX-37, same as BL-60, same as BX-55H) and so on.

作為烷氧基甲基化三聚氰胺之具體例子,例如可舉出六甲氧基甲基三聚氰胺等。作為市售品,可舉出Japan Cytec Industries(股)(Former Mitsui Cytec(股))製甲氧基甲基型三聚氰胺化合物(商品名:Cymel(註冊商標)300、同301、同303、同350)、丁氧基甲基型三聚氰胺化合物(商品名:My coat(註冊商標)506、同508)、(股)三和化學製甲氧基甲基型三聚氰胺化合物(商品名:Nicarac(註冊商標)MW-30、同MW-22、同MW-11、同MS-001、同MX-002、同MX-730、同MX-750、同MX-035)、丁氧基甲基型三聚氰胺化合物(商品名:Nicarac(註冊商標)MX-45、同MX-410、同MX-302)等。Specific examples of the alkoxymethylated melamine include hexamethoxymethyl melamine and the like. Examples of commercially available products include methoxymethyl melamine compounds (trade names: Cymel (registered trademark) 300, same 301, same 303, and 350) made by Japan Cytec Industries (former Mitsui Cytec (stock)). ), Butoxymethyl-type melamine compounds (trade name: My coat (registered trademark) 506, same as 508), (share) Sanwa Chemical methoxymethyl-type melamine compounds (trade name: Nicarac (registered trademark) MW-30, same MW-22, same MW-11, same MS-001, same MX-002, same MX-730, same MX-750, same MX-035), butoxymethyl melamine compounds (commodity Name: Nicarac (registered trademark) MX-45 (same as MX-410, same as MX-302), etc.

又,亦可為將如此胺基之氫原子由羥甲基或烷氧基甲基所取代的三聚氰胺化合物、尿素化合物、乙二醇脲化合物及苯並胍胺化合物經縮合後所得之化合物。例如可舉出美國專利第6323310號所記載的由三聚氰胺化合物及苯並胍胺化合物所製造的高分子量之化合物。作為前述三聚氰胺化合物之市售品,可舉出商品名:Cymel(註冊商標)303等,作為前述苯並胍胺化合物之市售品,可舉出商品名:Cymel(註冊商標)1123(以上為Japan Cytec Industries(股)(Former Mitsui Cytec(股))製)等。Moreover, it may be a compound obtained by condensing a melamine compound, a urea compound, a glycol urea compound, and a benzoguanamine compound in which the hydrogen atom of the amine group is replaced by a methylol group or an alkoxymethyl group. For example, a high molecular weight compound produced from a melamine compound and a benzoguanamine compound described in US Patent No. 6323310 can be mentioned. Examples of commercially available products of the melamine compound include a trade name: Cymel (registered trademark) 303, and examples of commercially available products of the benzoguanamine compound include a trade name: Cymel (registered trademark) 1123 (above: Japan Cytec Industries (stock) (made by Former Mitsui Cytec (stock)), etc.

且,作為(B)成分的甲醇基、具有2個以上的烷氧基甲基的聚合物,其為使用以N-羥基甲基丙烯醯胺、N-甲氧基甲基甲基丙烯醯胺、N-乙氧基甲基丙烯醯胺、N-丁氧基甲基甲基丙烯醯胺等羥基甲基(即羥甲基)或烷氧基甲基所取代的丙烯醯胺化合物或甲基丙烯醯胺化合物而製造的聚合物。In addition, as a component having a methanol group of (B) and a polymer having two or more alkoxymethyl groups, N-hydroxymethacrylamide and N-methoxymethylmethacrylamine are used. Hydroxymethyl (i.e. hydroxymethyl) or alkoxymethyl substituted acrylamide compounds or methyl groups such as N-ethoxymethacrylamide, N-butoxymethylmethacrylamine, or alkoxymethyl A polymer made from an acrylamide compound.

作為如此聚合物,例如可舉出聚(N-丁氧基甲基丙烯醯胺)、N-丁氧基甲基丙烯醯胺與苯乙烯之共聚物、N-羥基甲基甲基丙烯醯胺與甲基甲基丙烯酸酯之共聚物、N-乙氧基甲基甲基丙烯醯胺與苯甲基甲基丙烯酸酯之共聚物,及N-丁氧基甲基丙烯醯胺與苯甲基甲基丙烯酸酯與2-羥基丙基甲基丙烯酸酯之共聚物等。Examples of such polymers include poly (N-butoxymethacrylamide), a copolymer of N-butoxymethacrylamide and styrene, and N-hydroxymethylmethacrylamide Copolymer with methyl methacrylate, copolymer of N-ethoxymethylmethacrylamide and benzylmethacrylate, and N-butoxymethacrylamide with benzyl Copolymers of methacrylate and 2-hydroxypropyl methacrylate, etc.

又作為如此聚合物亦可使用具有含N-烷氧基甲基與C=C雙鍵之聚合性基的聚合物。As such a polymer, a polymer having a polymerizable group containing an N-alkoxymethyl group and a C = C double bond can also be used.

作為含有C=C雙鍵之聚合性基,可舉出丙烯酸基、甲基丙烯酸基、乙烯基、烯丙基、馬來醯亞胺基等。Examples of the polymerizable group containing a C = C double bond include an acrylic group, a methacrylic group, a vinyl group, an allyl group, and a maleimide group.

欲得到如上述聚合物之方法並無特別限定。若要舉出一例,其為預先藉由自由基聚合等聚合方法,生成具有特定官能基之丙烯酸聚合物。其次該的特定官能基與於末端具有不飽和鍵之化合物(以下稱為特定化合物)進行反應,於(B)成分的聚合物可導入含有C=C雙鍵之聚合性基。The method for obtaining the polymer as described above is not particularly limited. To give an example, this is an acrylic polymer having a specific functional group by a polymerization method such as radical polymerization in advance. Next, the specific functional group reacts with a compound having an unsaturated bond at its terminal (hereinafter referred to as a specific compound), and a polymerizable group containing a C = C double bond can be introduced into the polymer of the component (B).

於此,所謂特定官能基表示,羧基、縮水甘油基、羥基、具有活性氫之胺基、酚性羥基或者異氰酸酯基等官能基,或選自此等的複數種官能基。Here, the specific functional group means a functional group such as a carboxyl group, a glycidyl group, a hydroxyl group, an amine group having an active hydrogen, a phenolic hydroxyl group, or an isocyanate group, or a plurality of functional groups selected from these.

對於上述反應,特定官能基,與特定化合物所具有的官能基之與反應相關的基之較佳組合為羧基與環氧基、羥基與異氰酸酯基、酚性羥基與環氧基、羧基與異氰酸酯基、胺基與異氰酸酯基或羥基與酸氯化物基等。更佳的組合為羧基與縮水甘油基甲基丙烯酸酯,或羥基與異氰酸酯乙基甲基丙烯酸酯。For the above reaction, the preferred combination of the specific functional group and the reaction-related groups of the functional group of the specific compound is a carboxyl group and an epoxy group, a hydroxyl group and an isocyanate group, a phenolic hydroxyl group and an epoxy group, and a carboxyl group and an isocyanate group , Amine and isocyanate groups or hydroxyl and acid chloride groups. More preferred combinations are carboxyl and glycidyl methacrylate, or hydroxyl and isocyanate ethyl methacrylate.

如此聚合物之重量平均分子量(聚苯乙烯換算值)為1,000~500,000,以2,000~200,000為佳,較佳為3,000~150,000,更佳為3,000~50,000。The weight average molecular weight (polystyrene equivalent) of the polymer is 1,000 to 500,000, preferably 2,000 to 200,000, more preferably 3,000 to 150,000, and more preferably 3,000 to 50,000.

又,作為(B)成分的具有2個以上選自由羥基、羧基、醯胺基、胺基,及烷氧基矽基所成群的至少1個基之單體或聚合物,例如可舉出丙烯酸聚合物、聚醯胺酸、聚醯亞胺、聚乙烯醇、聚酯、聚酯聚羧酸、聚醚多元醇、聚酯多元醇、聚碳酸酯多元醇、聚己內酯多元醇、聚亞烷基亞胺、聚烯丙基胺、纖維素類(纖維素或其衍生物)、酚酚醛清漆樹脂、三聚氰胺甲醛樹脂等具有直鏈結構或分支結構之聚合物,環糊精類等的環狀聚合物等。Further, as the component (B), a monomer or polymer having at least one group selected from the group consisting of a hydroxyl group, a carboxyl group, a amine group, an amine group, and an alkoxysilyl group, and examples thereof include, for example, Acrylic polymer, polyamic acid, polyimide, polyvinyl alcohol, polyester, polyester polycarboxylic acid, polyether polyol, polyester polyol, polycarbonate polyol, polycaprolactone polyol, Polyalkyleneimines, polyallylamines, celluloses (cellulose or its derivatives), phenol novolac resins, melamine formaldehyde resins and other polymers with linear or branched structures, cyclodextrin, etc. Cyclic polymer and so on.

較佳可舉出丙烯酸聚合物、羥基烷基環糊精類、纖維素類、聚醚多元醇、聚酯多元醇、聚碳酸酯多元醇及聚己內酯多元醇。Preferred examples include acrylic polymers, hydroxyalkyl cyclodextrins, celluloses, polyether polyols, polyester polyols, polycarbonate polyols, and polycaprolactone polyols.

作為(B)成分的聚合物時之較佳一例的丙烯酸聚合物,其為將具有丙烯酸、甲基丙烯酸、苯乙烯、乙烯基化合物等不飽和雙鍵之單體經聚合所得之聚合物,若為將含有具有特定官能基的單體之單體或其混合物進行聚合所得之聚合物即可,構成丙烯酸聚合物之高分子的主鏈之骨架及側鏈的種類等並無特別限定。A preferred example of the acrylic polymer as the polymer of component (B) is a polymer obtained by polymerizing a monomer having unsaturated double bonds such as acrylic acid, methacrylic acid, styrene, and a vinyl compound. The polymer may be a polymer obtained by polymerizing a monomer or a mixture containing a monomer having a specific functional group, and the type of the backbone and side chain of the main chain of the polymer constituting the acrylic polymer is not particularly limited.

作為具有特定官能基之單體,可舉出具有聚乙二醇酯基之單體、具有碳原子數2~5的羥基烷基酯基之單體、具有酚性羥基之單體、具有羧基之單體、具有胺基之單體、具有烷氧基矽基以及乙醯乙醯基所示基的單體。Examples of the monomer having a specific functional group include a monomer having a polyethylene glycol ester group, a monomer having a hydroxyalkyl ester group having 2 to 5 carbon atoms, a monomer having a phenolic hydroxyl group, and a carboxyl group. Monomers, monomers having an amine group, monomers having an alkoxysilyl group, and a monomer represented by ethoxyethyl.

作為上述具有聚乙二醇酯基之單體,可舉出H-(OCH2 CH2 )n -OH的單丙烯酸酯或單甲基丙烯酸酯。該n值為2~50,較佳為2~10。Examples of the monomer having a polyethylene glycol ester group include a monoacrylate or a monomethacrylate of H- (OCH 2 CH 2 ) n -OH. The n value is 2 to 50, and preferably 2 to 10.

作為上述具有碳原子數2~5的羥基烷基酯基之單體,例如可舉出2-羥基乙基甲基丙烯酸酯、2-羥基乙基丙烯酸酯、2-羥基丙基甲基丙烯酸酯、2-羥基丙基丙烯酸酯、4-羥基丁基丙烯酸酯、4-羥基丁基甲基丙烯酸酯。Examples of the monomer having a hydroxyalkyl ester group having 2 to 5 carbon atoms include 2-hydroxyethyl methacrylate, 2-hydroxyethyl acrylate, and 2-hydroxypropyl methacrylate. , 2-hydroxypropyl acrylate, 4-hydroxybutyl acrylate, 4-hydroxybutyl methacrylate.

作為上述具有酚性羥基的單體,例如可舉出p-羥基苯乙烯、m-羥基苯乙烯、o-羥基苯乙烯。Examples of the monomer having a phenolic hydroxyl group include p-hydroxystyrene, m-hydroxystyrene, and o-hydroxystyrene.

作為上述具有羧基之單體,例如可舉出丙烯酸、甲基丙烯酸、乙烯基安息香酸。Examples of the monomer having a carboxyl group include acrylic acid, methacrylic acid, and vinyl benzoic acid.

作為上述側鏈具有胺基之單體,例如可舉出2-胺基乙基丙烯酸酯、2-胺基乙基甲基丙烯酸酯、胺基丙基丙烯酸酯及胺基丙基甲基丙烯酸酯。Examples of the monomer having an amine group in the side chain include 2-aminoethylacrylate, 2-aminoethylmethacrylate, aminopropylacrylate, and aminopropylmethacrylate .

作為上述側鏈具有烷氧基矽基之單體,例如可舉出3-丙烯醯氧基丙基三甲氧基矽烷、3-丙烯醯氧基丙基三乙氧基矽烷、3-甲基丙烯醯氧基丙基三甲氧基矽烷、3-甲基丙烯醯氧基丙基三甲氧基矽烷、乙烯基三甲氧基矽烷、乙烯基三乙氧基矽烷、烯丙基三甲氧基矽烷及烯丙基三乙氧基矽烷等。Examples of the monomer having an alkoxysilyl group in the side chain include 3-propenyloxypropyltrimethoxysilane, 3-propenyloxypropyltriethoxysilane, and 3-methacryl Alkoxypropyltrimethoxysilane, 3-methacryloxypropyltrimethoxysilane, vinyltrimethoxysilane, vinyltriethoxysilane, allyltrimethoxysilane and allyl Triethoxysilane and the like.

又,對於本實施形態,在合成(B)成分之例子的丙烯酸聚合物時,以不損害本發明之效果下,可併用不具有羥基、羧基、醯胺基、胺基及烷氧基矽基所示基中任一種的單體。In addition, in the present embodiment, when synthesizing the acrylic polymer as an example of the component (B), the hydroxyl group, carboxyl group, amido group, amine group, and alkoxysilyl group may be used in combination without impairing the effects of the present invention. Monomer of any of the groups shown.

作為該單體之具體例子,可舉出丙烯酸酯化合物、甲基丙烯酸酯化合物、馬來醯亞胺化合物、丙烯腈、馬來酸酐、苯乙烯化合物及乙烯基化合物等。Specific examples of the monomer include an acrylate compound, a methacrylate compound, a maleimide compound, acrylonitrile, maleic anhydride, a styrene compound, and a vinyl compound.

作為丙烯酸酯化合物,例如舉出甲基丙烯酸酯、乙基丙烯酸酯、異丙基丙烯酸酯、苯甲基丙烯酸酯、萘丙烯酸酯、蒽基丙烯酸酯、蒽基甲基丙烯酸酯、苯基丙烯酸酯、2,2,2-三氟乙基丙烯酸酯、tert-丁基丙烯酸酯、環己基丙烯酸酯、異冰片基丙烯酸酯、2-甲氧基乙基丙烯酸酯、甲氧基三乙二醇丙烯酸酯、2-乙氧基乙基丙烯酸酯、四氫糠基丙烯酸酯、3-甲氧基丁基丙烯酸酯、2-甲基-2-金剛烷基丙烯酸酯、2-丙基-2-金剛烷基丙烯酸酯、8-甲基-8-三環癸基丙烯酸酯,及8-乙基-8-三環癸基丙烯酸酯等。Examples of the acrylate compound include methacrylate, ethacrylate, isopropyl acrylate, benzyl acrylate, naphthalene acrylate, anthryl acrylate, anthryl methacrylate, and phenyl acrylate , 2,2,2-trifluoroethyl acrylate, tert-butyl acrylate, cyclohexyl acrylate, isobornyl acrylate, 2-methoxyethyl acrylate, methoxytriethylene glycol acrylic acid Ester, 2-ethoxyethyl acrylate, tetrahydrofurfuryl acrylate, 3-methoxybutyl acrylate, 2-methyl-2-adamantyl acrylate, 2-propyl-2-adamantine Alkyl acrylate, 8-methyl-8-tricyclodecyl acrylate, and 8-ethyl-8-tricyclodecyl acrylate.

作為甲基丙烯酸酯化合物,例如可舉出甲基甲基丙烯酸酯、乙基甲基丙烯酸酯、異丙基甲基丙烯酸酯、苯甲基甲基丙烯酸酯、萘甲基丙烯酸酯、蒽基甲基丙烯酸酯、蒽基甲基甲基丙烯酸酯、苯基甲基丙烯酸酯、2,2,2-三氟乙基甲基丙烯酸酯、tert-丁基甲基丙烯酸酯、環己基甲基丙烯酸酯、異冰片基甲基丙烯酸酯、2-甲氧基乙基甲基丙烯酸酯、甲氧基三乙二醇甲基丙烯酸酯、2-乙氧基乙基甲基丙烯酸酯、四氫糠基甲基丙烯酸酯、3-甲氧基丁基甲基丙烯酸酯、2-甲基-2-金剛烷基甲基丙烯酸酯、2-丙基-2-金剛烷基甲基丙烯酸酯、8-甲基-8-三環癸基甲基丙烯酸酯,及8-乙基-8-三環癸基甲基丙烯酸酯等。Examples of the methacrylate compound include methmethacrylate, ethylmethacrylate, isopropylmethacrylate, benzylmethacrylate, naphthylmethacrylate, and anthracenemethyl Acrylate, anthryl methacrylate, phenyl methacrylate, 2,2,2-trifluoroethyl methacrylate, tert-butyl methacrylate, cyclohexyl methacrylate, isopropyl Bornyl methacrylate, 2-methoxyethyl methacrylate, methoxytriethylene glycol methacrylate, 2-ethoxyethyl methacrylate, tetrahydrofurfuryl methacrylate Ester, 3-methoxybutyl methacrylate, 2-methyl-2-adamantyl methacrylate, 2-propyl-2-adamantyl methacrylate, 8-methyl-8-tri Cyclodecyl methacrylate, and 8-ethyl-8-tricyclodecyl methacrylate and the like.

作為馬來醯亞胺化合物,例如可舉出馬來醯亞胺、N-甲基馬來醯亞胺、N-苯基馬來醯亞胺,及N-環己基馬來醯亞胺等。Examples of the maleimide compound include maleimide, N-methylmaleimide, N-phenylmaleimide, and N-cyclohexylmaleimide.

作為苯乙烯化合物,例如可舉出苯乙烯、甲基苯乙烯、氯苯乙烯、溴苯乙烯等。Examples of the styrene compound include styrene, methylstyrene, chlorostyrene, and bromostyrene.

作為乙烯基化合物,例如可舉出乙烯基醚、甲基乙烯基醚、苯甲基乙烯基醚、2-羥基乙基乙烯基醚、苯基乙烯基醚,及丙基乙烯基醚等。Examples of the vinyl compound include vinyl ether, methyl vinyl ether, benzyl vinyl ether, 2-hydroxyethyl vinyl ether, phenyl vinyl ether, and propyl vinyl ether.

欲得到(B)成分之例子的丙烯酸聚合物時所使用的具有特定官能基之單體的使用量為,依據欲得到(B)成分之丙烯酸聚合物時所使用全單體的合計量,以2莫耳%以上者為佳。具有特定官能基之單體若過小時,所得之硬化膜的耐溶劑性容易變得不充分。The amount of the monomer having a specific functional group used to obtain the acrylic polymer of the example of the component (B) is based on the total amount of all monomers used to obtain the acrylic polymer of the (B) component. Above 2 mole% is preferred. If the monomer having a specific functional group is too small, the solvent resistance of the obtained cured film tends to be insufficient.

欲得到(B)成分之例子的丙烯酸聚合物之方法並無特別限定,例如對於將含有具有特定官能基之單體的單體、依據所需不具有特定官能基之單體與聚合起始劑等共存的溶劑,在50℃~110℃的溫度下進行聚合反應而得。此時所使用的溶劑若為可溶解具有特定官能基之單體、依據所需使用的不具有特定官能基之單體及聚合起始劑等者即可,並無特別限定。作為具體例子,如後述[溶劑]之項所記載。The method for obtaining the acrylic polymer as an example of the component (B) is not particularly limited. For example, a monomer containing a monomer having a specific functional group, a monomer having no specific functional group and a polymerization initiator as required It can be obtained by performing a polymerization reaction at a temperature of 50 ° C to 110 ° C, such as a coexisting solvent. The solvent used at this time is not particularly limited as long as it is capable of dissolving a monomer having a specific functional group, a monomer not having a specific functional group, a polymerization initiator, etc., as required. As a specific example, it will be described in the section of [solvent] described later.

由以上方法所得之(B)成分的例子之丙烯酸聚合物,通常為溶解於溶劑之溶液狀態。The acrylic polymer as an example of the component (B) obtained by the above method is usually in a solution state dissolved in a solvent.

又,將由上述方法所得之(B)成分的例子之丙烯酸聚合物的溶液投入於在攪拌下之二乙基醚或水等中,使其再沈澱,將所生成的沈澱物經過濾・洗淨後,在常壓或減壓下使其常溫乾燥或加熱乾燥,可得到(B)成分之例子的丙烯酸聚合物之粉體。藉由上述操作,可除去與(B)成分的例子之丙烯酸聚合物共存之聚合起始劑及未反應的單體,其結果,可得到經純化之(B)成分的例子之丙烯酸聚合物的粉體。若在一次操作下無法充分純化時,可將所得之粉體再次溶解於溶劑中,重複上述操作進行即可。In addition, the solution of the acrylic polymer of the example of the component (B) obtained by the above method was put into diethyl ether or water under stirring to reprecipitate, and the resulting precipitate was filtered and washed. Then, it is made to dry at normal temperature or heat-dry under normal pressure or reduced pressure, and the powder of the acrylic polymer which is an example of (B) component can be obtained. By the above operation, a polymerization initiator and an unreacted monomer that coexist with the acrylic polymer of the example of the (B) component can be removed. As a result, the purified acrylic polymer of the example of the (B) component can be obtained. Powder. If sufficient purification cannot be performed in one operation, the obtained powder can be dissolved in the solvent again, and the above operations can be repeated.

(B)成分的較佳例子之丙烯酸聚合物中的重量平均分子量以3000~200000者為佳,以4000~150000者為較佳,以5000~100000者為更佳。若為重量平均分子量超過200000之過大者時,對溶劑之溶解性降低而使處理性降低之情況產生,重量平均分子量若未達3000之較小者時,於熱硬化時變得硬化不足而降低溶劑耐性之情況產生。且,重量平均分子量為藉由凝膠滲透層析法(GPC),且使用聚苯乙烯作為標準試料所得之值。以下本說明書中所記載亦同樣。The weight average molecular weight in the acrylic polymer of a preferable example of the component (B) is preferably 3,000 to 200,000, more preferably 4,000 to 150,000, and even more preferably 5,000 to 100,000. If the weight average molecular weight exceeds 200,000, the solubility to the solvent will be reduced to reduce the handleability. If the weight average molecular weight is less than 3,000, it will become insufficiently hardened during thermal curing and decrease. Solvent resistance occurs. The weight-average molecular weight is a value obtained by gel permeation chromatography (GPC) using polystyrene as a standard sample. The same applies to the following descriptions.

其次,作為(B)成分之一較佳例子之聚醚多元醇,可舉出聚乙二醇、聚丙二醇、丙二醇或雙酚A、三乙二醇、山梨醇等多元醇中加成環氧丙烷或聚乙二醇、聚丙二醇等者。作為聚醚多元醇的具體例子,可舉出ADEKA製Adeka polyetherP系列、G系列、EDP系列、BPX系列、FC系列、CM系列、日油製UNIOX(註冊商標)HC-40、HC-60、ST-30E、ST-40E、G-450、G-750、UNIOL(註冊商標)TG-330、TG-1000、TG-3000、TG-4000、HS-1600D、DA-400、DA-700、DB-400、非離子(註冊商標)LT-221、ST-221、OT-221等。Next, as one of the preferred examples of the component (B), the polyether polyol includes polyethylene glycol, polypropylene glycol, propylene glycol, or polyhydric alcohols such as bisphenol A, triethylene glycol, and sorbitol. Propane or polyethylene glycol, polypropylene glycol, etc. Specific examples of the polyether polyol include Adeka polyetherP series, G series, EDP series, BPX series, FC series, CM series, and UNIOX (registered trademark) HC-40, HC-60, and ST manufactured by ADEKA. -30E, ST-40E, G-450, G-750, UNIOL (registered trademark) TG-330, TG-1000, TG-3000, TG-4000, HS-1600D, DA-400, DA-700, DB- 400, non-ion (registered trademark) LT-221, ST-221, OT-221, etc.

作為(B)成分之較佳一例子的聚酯多元醇,可舉出將己二酸、癸二酸、間苯二甲酸等多元羧酸與乙二醇、丙二醇、丁二醇、聚乙二醇、聚丙二醇等二醇進行反應者。作為聚酯多元醇之具體例子,可舉出DIC製之Polylite(註冊商標)OD-X-286、OD-X-102、OD-X-355、OD-X-2330、OD-X-240、OD-X-668、OD-X-2108、OD-X-2376、OD-X-2044、OD-X-688、OD-X-2068、OD-X-2547、OD-X-2420、OD-X-2523、OD-X-2555、OD-X-2560、Kuraray製多元醇P-510、P-1010、P-2010、P-3010、P-4010、P-5010、P-6010、F-510、F-1010、F-2010、F-3010、P-1011、P-2011、P-2013、P-2030、N-2010、PNNA-2016等。Polyester polyols which are preferred examples of the component (B) include polybasic carboxylic acids such as adipic acid, sebacic acid, and isophthalic acid, and ethylene glycol, propylene glycol, butanediol, and polyethylene glycol. Those reacting with diols such as alcohol and polypropylene glycol. Specific examples of polyester polyols include Polylite (registered trademark) OD-X-286, OD-X-102, OD-X-355, OD-X-2330, OD-X-240, OD-X-668, OD-X-2108, OD-X-2376, OD-X-2044, OD-X-688, OD-X-2068, OD-X-2547, OD-X-2420, OD- X-2523, OD-X-2555, OD-X-2560, Kuraray polyols P-510, P-1010, P-2010, P-3010, P-4010, P-5010, P-6010, F- 510, F-1010, F-2010, F-3010, P-1011, P-2011, P-2013, P-2030, N-2010, PNNA-2016, etc.

作為(B)成分之較佳一例子的聚己內酯多元醇,可舉出將三羥甲基丙烷或乙二醇等多元醇作為起始劑之使ε-己內酯進行開環聚合者。作為聚己內酯多元醇之具體例子,可舉出DIC製Polylite(註冊商標)OD-X-2155、OD-X-640、OD-X-2568、大賽璐化學製Plaxel(註冊商標)205、L205AL、205U、208、210、212、L212AL、220、230、240、303、305、308、312、320等。As a preferred example of the (B) component, a polycaprolactone polyol includes a ring-opening polymerization of ε-caprolactone using a polyhydric alcohol such as trimethylolpropane or ethylene glycol as a starter. . Specific examples of polycaprolactone polyols include Polylite (registered trademark) OD-X-2155, OD-X-640, OD-X-2568, manufactured by DIC, Plaxel (registered trademark) 205, manufactured by Daicel Chemical, L205AL, 205U, 208, 210, 212, L212AL, 220, 230, 240, 303, 305, 308, 312, 320, etc.

作為(B)成分之較佳一例子的聚碳酸酯多元醇,可舉出將三羥甲基丙烷或乙二醇等多元醇,與碳酸二乙基、碳酸二苯基、伸乙基碳酸酯等進行反應者。作為聚碳酸酯多元醇的具體例子,可舉出大賽璐化學製Plaxel(註冊商標)CD205、CD205PL、CD210、CD220、Kuraray製的C-590、C-1050、C-2050、C-2090、C-3090等。As a preferable example of the polycarbonate polyol as the component (B), a polyhydric alcohol such as trimethylolpropane or ethylene glycol, and diethyl carbonate, diphenyl carbonate, and ethyl carbonate are exemplified. Wait for a response. Specific examples of the polycarbonate polyol include Plaxel (registered trademark) CD205, CD205PL, CD210, CD220 manufactured by Daicel Chemical, and C-590, C-1050, C-2050, C-2090, C manufactured by Kuraray. -3090 and so on.

作為(B)成分之較佳一例子的纖維素,可舉出羥基乙基纖維素、羥基丙基纖維素等羥基烷基纖維素類、羥基乙基甲基纖維素、羥基丙基甲基纖維素、羥基乙基乙基纖維素等羥基烷基烷基纖維素類及纖維素等,例如以羥基乙基纖維素、羥基丙基纖維素等羥基烷基纖維素類為佳。Examples of cellulose as a preferred component (B) include hydroxyalkyl celluloses such as hydroxyethyl cellulose and hydroxypropyl cellulose, hydroxyethyl methyl cellulose, and hydroxypropyl methyl fiber Hydroxyalkyl celluloses such as cellulose, hydroxyethyl ethyl cellulose, and cellulose are preferred, and hydroxyalkyl celluloses such as hydroxyethyl cellulose and hydroxypropyl cellulose are preferred.

作為(B)成分的聚合物之較佳一例子的環糊精,可舉出α-環糊精、β-環糊精及γ-環糊精等的環糊精、甲基-α-環糊精、甲基-β-環糊精及甲基-γ-環糊精等甲基化環糊精、羥基甲基-α-環糊精、羥基甲基-β-環糊精、羥基甲基-γ-環糊精、2-羥基乙基-α-環糊精、2-羥基乙基-β-環糊精、2-羥基乙基-γ-環糊精、2-羥基丙基-α-環糊精、2-羥基丙基-β-環糊精、2-羥基丙基-γ-環糊精、3-羥基丙基-α-環糊精、3-羥基丙基-β-環糊精、3-羥基丙基-γ-環糊精、2,3-二羥基丙基-α-環糊精、2,3-二羥基丙基-β-環糊精、2,3-二羥基丙基-γ-環糊精等羥基烷基環糊精等。Examples of the cyclodextrin which is a preferable example of the polymer of the component (B) include cyclodextrin such as α-cyclodextrin, β-cyclodextrin and γ-cyclodextrin, and methyl-α-cyclodextrin. Methylated cyclodextrins such as dextrin, methyl-β-cyclodextrin and methyl-γ-cyclodextrin, hydroxymethyl-α-cyclodextrin, hydroxymethyl-β-cyclodextrin, hydroxymethyl -Γ-cyclodextrin, 2-hydroxyethyl-α-cyclodextrin, 2-hydroxyethyl-β-cyclodextrin, 2-hydroxyethyl-γ-cyclodextrin, 2-hydroxypropyl- α-cyclodextrin, 2-hydroxypropyl-β-cyclodextrin, 2-hydroxypropyl-γ-cyclodextrin, 3-hydroxypropyl-α-cyclodextrin, 3-hydroxypropyl-β- Cyclodextrin, 3-hydroxypropyl-γ-cyclodextrin, 2,3-dihydroxypropyl-α-cyclodextrin, 2,3-dihydroxypropyl-β-cyclodextrin, 2,3- Dihydroxypropyl-γ-cyclodextrin and the like.

作為(B)成分物之較佳一例子的三聚氰胺甲醛樹脂為聚縮合三聚氰胺與甲醛而得之樹脂,其如下述式所示。As a preferred example of the component (B), the melamine formaldehyde resin is a resin obtained by polycondensing melamine and formaldehyde, which is represented by the following formula.

上述式中,R21 表示氫原子或碳原子數1至4的烷基,n表示重複單位的數目之自然數。In the above formula, R 21 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, and n represents a natural number of the number of repeating units.

三聚氰胺甲醛樹脂由保存安定性之觀點來看,以三聚氰胺與甲醛之聚縮合時所生成的羥甲基經烷基化者為佳。From the standpoint of storage stability, the melamine formaldehyde resin is preferably one in which the methylol group formed during the polycondensation of melamine and formaldehyde is alkylated.

欲得到三聚氰胺甲醛樹脂之方法並無特別限定,一般為混合三聚氰胺與甲醛,使用碳酸鈉或氨等弱鹼性後,在60℃~100℃進行加熱而合成。可進一步與醇進行反應後使羥甲基進行烷氧基化。The method for obtaining the melamine formaldehyde resin is not particularly limited. Generally, it is synthesized by mixing melamine and formaldehyde, using a weak alkali such as sodium carbonate or ammonia, and heating at 60 ° C to 100 ° C. After further reacting with an alcohol, the methylol group can be alkoxylated.

三聚氰胺甲醛樹脂之重量平均分子量以250~5000者為佳,以300~4000者為較佳,以350~3500者為更佳。重量平均分子量若超過5000之過大者時,對於溶劑之溶解性會降低且處理性降低之情況會產生,若重量平均分子量未達250之過小者時,於熱硬化時會變的硬化不足且無法充分地提高溶劑耐性之情況會產生。The weight average molecular weight of the melamine formaldehyde resin is preferably from 250 to 5,000, more preferably from 300 to 4,000, and even more preferably from 350 to 3500. If the weight average molecular weight exceeds 5000, the solubility to the solvent will decrease and handling properties will decrease. If the weight average molecular weight is less than 250, the hardness will be insufficient and cannot be cured during thermal curing. There are cases where the solvent resistance is sufficiently improved.

對於本發明之實施形態為(B)成分的較佳一例的三聚氰胺甲醛樹脂可在液體形態下,或者將經純化的液體再溶解於後述溶劑中的溶液形態下使用。The melamine formaldehyde resin which is a preferred example of the component (B) according to the embodiment of the present invention can be used in a liquid form or in a solution form in which a purified liquid is redissolved in a solvent described later.

作為(B)成分之較佳一例子的酚酚醛清漆樹脂,例如可舉出酚-甲醛聚縮合物等。As a preferable example of the (B) component, a phenol novolak resin includes a phenol-formaldehyde polycondensate and the like.

對於本實施形態之硬化膜形成組成物,(B)成分的聚合物可在粉體形態下,或在將經純化的粉末再溶解於後述溶劑之溶液形態下使用。In the cured film-forming composition of this embodiment, the polymer of component (B) can be used in the form of a powder or in the form of a solution in which a purified powder is redissolved in a solvent described later.

又,對於本實施形態之硬化膜形成組成物,(B)成分可為作為(B)成分而例示之單體及聚合物的複數種之混合物。In the cured film-forming composition of the present embodiment, the component (B) may be a mixture of a plurality of monomers and polymers exemplified as the component (B).

含有本發明之硬化膜形成組成物中的(B)成分時之含有量,對於(A)成分之聚合物的合計量100質量份而言,以400質量份以下為佳,較佳為10質量份~380質量份,更佳為40質量份~360質量份。(B)成分的含有量過大時,液晶配向性容易降低。The content of the component (B) in the cured film-forming composition of the present invention is preferably 400 parts by mass or less, and more preferably 10 parts by mass based on 100 parts by mass of the total amount of the polymer of the component (A). Parts to 380 parts by mass, and more preferably 40 parts to 360 parts by mass. When the content of the component (B) is too large, liquid crystal alignment is liable to decrease.

<(C)成分>   本發明之硬化膜形成組成物除前述(A)成分以外,可進一步含有作為(C)成分之交聯觸媒。   作為(C)成分之交聯觸媒,例如可適用酸或熱酸產生劑。該(C)成分在促進本發明之硬化膜形成組成物的熱硬化反應上為有效。   (C)成分,作為上述酸,具體可舉出含有磺酸基的化合物、鹽酸或其鹽。而作為上述熱酸產生劑,若為於加熱處理時進行熱分解後產生酸的化合物,即在溫度80℃至250℃下進行熱分解而產生酸的化合物即可,並無特別限定。<(C) component> 硬化 The cured film-forming composition of the present invention may further contain a crosslinking catalyst as the (C) component in addition to the component (A). As a cross-linking catalyst of the component (C), for example, an acid or a thermal acid generator can be applied. This (C) component is effective in accelerating the thermosetting reaction of the cured film-forming composition of the present invention. As the hydrazone (C) component, specific examples of the acid include a compound containing a sulfonic acid group, hydrochloric acid, or a salt thereof. The thermal acid generator is not particularly limited as long as it is a compound that generates an acid after thermal decomposition during heat treatment, that is, a compound that generates an acid by thermal decomposition at a temperature of 80 ° C to 250 ° C.

作為上述酸的具體例子,例如可舉出鹽酸或其鹽;甲磺酸、乙磺酸、丙烷磺酸、丁烷磺酸、戊烷磺酸、辛烷磺酸、苯磺酸、p-甲苯磺酸、樟腦磺酸、三氟甲磺酸、p-酚磺酸、2-萘磺酸、三甲苯磺酸、p-二甲苯-2-磺酸、m-二甲苯-2-磺酸、4-乙基苯磺酸、1H,1H,2H,2H-全氟辛烷磺酸、全氟(2-乙氧基乙烷)磺酸、五氟乙磺酸、九氟丁烷-1-磺酸、十二烷基苯磺酸等磺酸基含有化合物或其水合物或鹽等。Specific examples of the acid include hydrochloric acid or a salt thereof; methanesulfonic acid, ethanesulfonic acid, propanesulfonic acid, butanesulfonic acid, pentanesulfonic acid, octanesulfonic acid, benzenesulfonic acid, and p-toluene. Sulfonic acid, camphor sulfonic acid, trifluoromethanesulfonic acid, p-phenolsulfonic acid, 2-naphthalenesulfonic acid, xylenesulfonic acid, p-xylene-2-sulfonic acid, m-xylene-2-sulfonic acid, 4-ethylbenzenesulfonic acid, 1H, 1H, 2H, 2H-perfluorooctanesulfonic acid, perfluoro (2-ethoxyethane) sulfonic acid, pentafluoroethanesulfonic acid, nonafluorobutane-1- The sulfonic acid group such as sulfonic acid and dodecylbenzenesulfonic acid contains a compound or a hydrate or a salt thereof.

又,作為藉由熱而產生酸的化合物,例如可舉出雙(甲苯磺醯基氧基)乙烷、雙(甲苯磺醯基氧基)丙烷、雙(甲苯磺醯基氧基)丁烷、p-硝基苯甲基甲苯磺酸酯、o-硝基苯甲基甲苯磺酸酯、1,2,3-伸苯基參(甲基磺酸鹽)、p-甲苯磺酸吡啶鎓鹽、p-甲苯磺酸莫耳鎓鹽、p-甲苯磺酸乙基酯、p-甲苯磺酸丙基酯、p-甲苯磺酸丁基酯、p-甲苯磺酸異丁基酯、p-甲苯磺酸甲基酯、p-甲苯磺酸苯乙基酯、氰基甲基p-甲苯磺酸鹽、2,2,2-三氟乙基p-甲苯磺酸鹽、2-羥基丁基p-甲苯磺酸鹽、N-乙基-p-甲苯磺醯胺,進一步可舉出下述式所示化合物:Examples of the compound that generates an acid by heat include bis (tosylsulfonyloxy) ethane, bis (tosylsulfonyloxy) propane, and bis (tosylsulfonyloxy) butane. , P-nitrobenzyltoluenesulfonate, o-nitrobenzyltoluenesulfonate, 1,2,3-phenylene ginseng (methanesulfonate), p-pyridinium tosylate Salt, p-toluenesulfonic acid mormonium salt, p-toluenesulfonic acid ethyl ester, p-toluenesulfonic acid propyl ester, p-toluenesulfonic acid butyl ester, p-toluenesulfonic acid isobutyl ester, p -Toluenesulfonic acid methyl ester, p-toluenesulfonic acid phenethyl ester, cyanomethyl p-toluenesulfonic acid salt, 2,2,2-trifluoroethyl p-toluenesulfonic acid salt, 2-hydroxybutane Examples of the p-toluenesulfonate and N-ethyl-p-toluenesulfonamide include compounds represented by the following formula:

含有本發明之硬化膜形成組成物中之(C)成分時的含有量對於(A)成分之聚合物100質量份而言,以0.01質量份~20質量份為佳,較佳為0.1質量份~15質量份,更佳為0.5質量份~10質量份。將(C)成分的含有量設定在0.01質量份以上時,可賦予充分熱硬化性及溶劑耐性。然而,若比20質量份多時,組成物之保存安定性會降低之情況會產生。The content of the component (C) in the cured film-forming composition of the present invention is preferably 0.01 to 20 parts by mass, and more preferably 0.1 part by mass with respect to 100 parts by mass of the polymer of the component (A). 15 mass parts, more preferably 0.5 mass parts to 10 mass parts. When the content of the component (C) is 0.01 parts by mass or more, sufficient thermosetting properties and solvent resistance can be imparted. However, if it is more than 20 parts by mass, the storage stability of the composition may decrease.

<(D)成分>   本發明中作為(D)成分,可含有具有1個以上的聚合性基,與選自由羥基、羧基、醯胺基、胺基及烷氧基矽基所成群的至少1個基A,或與該基A進行反應的至少1個基之化合物。此可提高所形成的硬化膜之接著性的成分(以下亦稱為密著提高成分)。<(D) component> 中 In the present invention, the component (D) may contain at least one polymerizable group and at least one group selected from the group consisting of a hydroxyl group, a carboxyl group, a fluorenylamino group, an amine group, and an alkoxysilyl group. One group A, or a compound having at least one group that reacts with the group A. This component can improve the adhesiveness of the formed cured film (hereinafter also referred to as an adhesion improving component).

將由含有(D)成分的本實施形態之硬化膜形成組成物所形成的硬化膜作為配向材料使用時,欲提高配向材料與聚合性液晶之層的密著性,聚合性液晶之聚合性官能基與配向材料之交聯反應部位可藉由共價鍵而連接。其結果,於本實施形態的配向材料上層合經硬化的聚合性液晶而成的本實施形態的相位差材料,即使在高溫高濕之條件下,亦可維持強密著性,可對剝離等顯示高耐久性。When the cured film formed from the cured film-forming composition of this embodiment containing the (D) component is used as an alignment material, the adhesiveness of the layer between the alignment material and the polymerizable liquid crystal is improved, and the polymerizable functional group of the polymerizable liquid crystal is used. The cross-linking reaction site with the alignment material may be connected by a covalent bond. As a result, the retardation material of this embodiment, which is formed by laminating a cured polymerizable liquid crystal on the alignment material of this embodiment, can maintain strong adhesion even under conditions of high temperature and high humidity, and can be peeled off. Shows high durability.

作為(D)成分,以具有選自羥基及N-烷氧基甲基的基,與聚合性基的單體及聚合物為佳。   作為如此(D)成分,可舉出具有羥基與(甲基)丙烯酸基之化合物、具有N-烷氧基甲基與(甲基)丙烯酸基之化合物、具有N-烷氧基甲基與(甲基)丙烯酸基之聚合物等。以下為各具體例子。The component (D) is preferably a monomer or polymer having a group selected from a hydroxyl group and an N-alkoxymethyl group, and a polymerizable group. Examples of the component (D) include compounds having a hydroxyl group and a (meth) acrylic group, compounds having an N-alkoxymethyl group and a (meth) acrylic group, and compounds having an N-alkoxymethyl group and ( (Meth) acrylic polymer. The following are specific examples.

作為(D)成分之一例子,可舉出含有羥基之多官能丙烯酸酯(以下亦稱為含有羥基之多官能丙烯酸酯)。   作為(D)成分的例子之含有羥基之多官能丙烯酸酯,例如可舉出季戊四醇三丙烯酸酯及二季戊四醇五丙烯酸酯等。An example of the component (D) includes a hydroxyl-containing polyfunctional acrylate (hereinafter also referred to as a hydroxyl-containing polyfunctional acrylate). As examples of the (D) component, the polyfunctional acrylate containing a hydroxyl group includes pentaerythritol triacrylate, dipentaerythritol pentaacrylate, and the like.

作為(D)成分的一例子,亦可舉出具有1個丙烯酸基與1個以上羥基之化合物。如此可舉出具有1個丙烯酸基與1個以上羥基之化合物的較佳例子。且,(D)成分的化合物並未限定於以下化合物例者。As an example of the (D) component, the compound which has one acrylic group and one or more hydroxyl groups can also be mentioned. As such, a preferable example of a compound having one acrylic group and one or more hydroxyl groups can be cited. In addition, the compound of (D) component is not limited to the following compound examples.

(上述式中,R11 表示氫原子或甲基,m表示1~10的整數) (In the above formula, R 11 represents a hydrogen atom or a methyl group, and m represents an integer of 1 to 10)

又,作為(D)成分之化合物,可舉出具有至少一個於1分子中含有C=C雙鍵之聚合性基與至少一個N-烷氧基甲基之化合物。Examples of the compound (D) include compounds having at least one polymerizable group containing a C = C double bond in one molecule and at least one N-alkoxymethyl group.

作為含有C=C雙鍵之聚合性基,可舉出丙烯酸基、甲基丙烯酸基、乙烯基、烯丙基、馬來醯亞胺基等。Examples of the polymerizable group containing a C = C double bond include an acrylic group, a methacrylic group, a vinyl group, an allyl group, and a maleimide group.

作為N-烷氧基甲基的N,即氮原子,可舉出醯胺的氮原子、硫代醯胺的氮原子、脲的氮原子、硫代脲的氮原子、胺基甲酸酯的氮原子、於含氮雜環的氮原子之鄰接位上鍵結的氮原子等。因此,作為N-烷氧基甲基,可選自由醯胺的氮原子、硫代醯胺的氮原子、脲的氮原子、硫代脲的氮原子、胺基甲酸酯的氮原子、於含氮雜環之氮原子的鄰接位上鍵結的氮原子等氮原子上鍵結烷氧基甲基之結構。Examples of the N of an N-alkoxymethyl group include a nitrogen atom, a nitrogen atom of amidine, a nitrogen atom of thioamidine, a nitrogen atom of urea, a nitrogen atom of thiourea, and A nitrogen atom, a nitrogen atom bonded to an adjacent position of a nitrogen atom of a nitrogen-containing heterocyclic ring, and the like. Therefore, as the N-alkoxymethyl group, a nitrogen atom of amidine, a nitrogen atom of thioamidine, a nitrogen atom of urea, a nitrogen atom of thiourea, a nitrogen atom of carbamate, or A structure in which an alkoxymethyl group is bonded to a nitrogen atom such as a nitrogen atom bonded to an adjacent position of a nitrogen atom of a nitrogen-containing heterocyclic ring.

作為(D)成分,若為具有上述基者即可,例如較佳為下述式(X1)所示化合物。(式中,R31 表示氫原子或甲基,R32 表示氫原子或直鏈狀或者分支鏈狀碳原子數1至10的烷基)The component (D) may be any compound having the aforementioned group. For example, a compound represented by the following formula (X1) is preferred. (In the formula, R 31 represents a hydrogen atom or a methyl group, and R 32 represents a hydrogen atom or a linear or branched chain alkyl group having 1 to 10 carbon atoms.)

作為上述碳原子數1至10的烷基,例如可舉出甲基、乙基、n-丙基、異丙基、n-丁基、異丁基、sec-丁基、tert-丁基、n-戊基、1-甲基-n-丁基、2-甲基-n-丁基、3-甲基-n-丁基、1,1-二甲基-n-丙基、1,2-二甲基-n-丙基、2,2-二甲基-n-丙基、1-乙基-n-丙基、n-己基、1-甲基-n-戊基、2-甲基-n-戊基、3-甲基-n-戊基、4-甲基-n-戊基、1,1-二甲基-n-丁基、1,2-二甲基-n-丁基、1,3-二甲基-n-丁基、2,2-二甲基-n-丁基、2,3-二甲基-n-丁基、3,3-二甲基-n-丁基、1-乙基-n-丁基、2-乙基-n-丁基、1,1,2-三甲基-n-丙基、1,2,2-三甲基-n-丙基、1-乙基-1-甲基-n-丙基、1-乙基-2-甲基-n-丙基、n-庚基、1-甲基-n-己基、2-甲基-n-己基、3-甲基-n-己基、1,1-二甲基-n-戊基、1,2-二甲基-n-戊基、1,3-二甲基-n-戊基、2,2-二甲基-n-戊基、2,3-二甲基-n-戊基、3,3-二甲基-n-戊基、1-乙基-n-戊基、2-乙基-n-戊基、3-乙基-n-戊基、1-甲基-1-乙基-n-丁基、1-甲基-2-乙基-n-丁基、1-乙基-2-甲基-n-丁基、2-甲基-2-乙基-n-丁基、2-乙基-3-甲基-n-丁基、n-辛基、1-甲基-n-庚基、2-甲基-n-庚基、3-甲基-n-庚基、1,1-二甲基-n-己基、1,2-二甲基-n-己基、1,3-二甲基-n-己基、2,2-二甲基-n-己基、2,3-二甲基-n-己基、3,3-二甲基-n-己基、1-乙基-n-己基、2-乙基-n-己基、3-乙基-n-己基、1-甲基-1-乙基-n-戊基、1-甲基-2-乙基-n-戊基、1-甲基-3-乙基-n-戊基、2-甲基-2-乙基-n-戊基、2-甲基-3-乙基-n-戊基、3-甲基-3-乙基-n-戊基、n-壬基、n-癸基等。Examples of the alkyl group having 1 to 10 carbon atoms include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, 1-methyl-n-butyl, 2-methyl-n-butyl, 3-methyl-n-butyl, 1,1-dimethyl-n-propyl, 1, 2-dimethyl-n-propyl, 2,2-dimethyl-n-propyl, 1-ethyl-n-propyl, n-hexyl, 1-methyl-n-pentyl, 2- Methyl-n-pentyl, 3-methyl-n-pentyl, 4-methyl-n-pentyl, 1,1-dimethyl-n-butyl, 1,2-dimethyl-n -Butyl, 1,3-dimethyl-n-butyl, 2,2-dimethyl-n-butyl, 2,3-dimethyl-n-butyl, 3,3-dimethyl -n-butyl, 1-ethyl-n-butyl, 2-ethyl-n-butyl, 1,1,2-trimethyl-n-propyl, 1,2,2-trimethyl -n-propyl, 1-ethyl-1-methyl-n-propyl, 1-ethyl-2-methyl-n-propyl, n-heptyl, 1-methyl-n-hexyl, 2-methyl-n-hexyl, 3-methyl-n-hexyl, 1,1-dimethyl-n-pentyl, 1,2-dimethyl-n-pentyl, 1,3-dimethyl -N-pentyl, 2,2-dimethyl-n-pentyl, 2,3-dimethyl-n-pentyl, 3,3-dimethyl-n-pentyl, 1-ethyl -n-pentyl, 2-ethyl-n-pentyl, 3-ethyl-n-pentyl, 1-methyl-1- -N-butyl, 1-methyl-2-ethyl-n-butyl, 1-ethyl-2-methyl-n-butyl, 2-methyl-2-ethyl-n-butyl Methyl, 2-ethyl-3-methyl-n-butyl, n-octyl, 1-methyl-n-heptyl, 2-methyl-n-heptyl, 3-methyl-n-heptyl Group, 1,1-dimethyl-n-hexyl, 1,2-dimethyl-n-hexyl, 1,3-dimethyl-n-hexyl, 2,2-dimethyl-n-hexyl, 2,3-dimethyl-n-hexyl, 3,3-dimethyl-n-hexyl, 1-ethyl-n-hexyl, 2-ethyl-n-hexyl, 3-ethyl-n-hexyl , 1-methyl-1-ethyl-n-pentyl, 1-methyl-2-ethyl-n-pentyl, 1-methyl-3-ethyl-n-pentyl, 2-methyl 2-ethyl-n-pentyl, 2-methyl-3-ethyl-n-pentyl, 3-methyl-3-ethyl-n-pentyl, n-nonyl, n-decyl Wait.

作為上述式(X1)所示化合物之具體例子,可舉出N-羥基甲基(甲基)丙烯醯胺、N-甲氧基甲基(甲基)丙烯醯胺、N-乙氧基甲基(甲基)丙烯醯胺、N-丁氧基甲基(甲基)丙烯醯胺等羥基甲基或者由烷氧基甲基所取代的丙烯醯胺化合物或甲基丙烯醯胺化合物。且所謂(甲基)丙烯醯胺為表示甲基丙烯醯胺與丙烯醯胺之雙方意思。Specific examples of the compound represented by the formula (X1) include N-hydroxymethyl (meth) acrylamide, N-methoxymethyl (meth) acrylamide, and N-ethoxymethyl. A hydroxymethyl group such as a methyl (meth) acrylamide, N-butoxymethyl (meth) acrylamide, or an acrylamide compound or a methacrylamine compound substituted with an alkoxymethyl group. The term "(meth) acrylamide" means both methacrylamide and acrylamide.

作為(D)成分的具有含有C=C雙鍵之聚合性基與N-烷氧基甲基之化合物的另一態樣,例如較佳可舉出下述式(X2)所示化合物。式中,R51 表示氫原子或甲基。   R52 表示含有碳原子數2至20的烷基、碳原子數5至6的1價脂肪族環基或碳原子數5至6的脂肪族環之1價脂肪族基,亦可於結構中含有醚鍵。   R53 表示直鏈狀或分支鏈狀碳原子數2至20的伸烷基、碳原子數5至6的2價脂肪族環基,或含有碳原子數5至6的脂肪族環之2價脂肪族基,亦可於結構中含有醚鍵。   R54 表示直鏈狀或分支鏈狀碳原子數1至20的2價至9價脂肪族基、碳原子數5至6的2價至9價脂肪族環基,或含有碳原子數5至6的脂肪族環之2價至9價脂肪族基,這些基之一個伸甲基或不相鄰的複數伸甲基可取代為醚鍵。   Z表示>NCOO-或-OCON<(其中,「-」表示1個結合鍵。又,「>」「<」表示2個結合鍵,且於任1個結合鍵上鍵結烷氧基甲基(即-OR52 基)鍵結)。   r為2以上9以下的自然數。As another aspect of the compound having a polymerizable group containing a C = C double bond and an N-alkoxymethyl group as the component (D), for example, a compound represented by the following formula (X2) is preferable. In the formula, R 51 represents a hydrogen atom or a methyl group. R 52 represents an alkyl group having 2 to 20 carbon atoms, a monovalent aliphatic cyclic group having 5 to 6 carbon atoms, or a monovalent aliphatic group having 5 to 6 carbon atoms in the aliphatic ring, and may also be in the structure Contains ether bonds. R 53 represents a linear or branched alkylene group having 2 to 20 carbon atoms, a divalent aliphatic cyclic group having 5 to 6 carbon atoms, or a divalent group containing an aliphatic ring having 5 to 6 carbon atoms. The aliphatic group may contain an ether bond in the structure. R 54 represents a linear or branched chain divalent to 9-valent aliphatic group having 1 to 20 carbon atoms, a divalent to 9-valent aliphatic cyclic group having 5 to 6 carbon atoms, or contains 5 to 6 carbon atoms A bivalent to 9-valent aliphatic group of the aliphatic ring of 6, one of these groups may be substituted with an methyl group or a non-adjacent plural methyl group may be substituted with an ether bond. Z represents> NCOO- or -OCON <(wherein "-" represents one bond. Also, ">""<" represents two bonds, and an alkoxymethyl group is bonded to any one of the bonds. (I.e. -OR 52 base) bonding). r is a natural number of 2 or more and 9 or less.

作為R53 定義中之碳原子數2至20的伸烷基之具體例子,可舉出自碳原子數2至20的烷基中進一步取出1個氫原子之2價基。   又,作為R54 定義中之碳原子數1至20的2價至9價脂肪族基之具體例子,可舉出自碳原子數1至20的烷基中進一步取出1至8個氫原子的2價至9價之基。Specific examples of the alkylene group having 2 to 20 carbon atoms in the definition of R 53 include a bivalent group in which one hydrogen atom is further taken out of the alkyl group having 2 to 20 carbon atoms. In addition, as a specific example of a divalent to 9-valent aliphatic group having 1 to 20 carbon atoms in the definition of R 54 , an example in which 1 to 8 hydrogen atoms are further taken out of an alkyl group having 1 to 20 carbon atoms Base of 2 to 9 valence.

碳原子數1的烷基為甲基,又作為碳原子數2至20的烷基之具體例子,可舉出乙基、n-丙基、i-丙基、n-丁基、i-丁基、s-丁基、t-丁基、n-戊基、1-甲基-n-丁基、2-甲基-n-丁基、3-甲基-n-丁基、1,1-二甲基-n-丙基、n-己基、1-甲基-n-戊基、2-甲基-n-戊基、1,1-二甲基-n-丁基、1-乙基-n-丁基、1,1,2-三甲基-n-丙基、n-庚基、n-辛基、n-壬基、n-癸基、n-十一烷基、n-十二烷基、n-十三烷基、n-十四烷基、n-十五烷基、n-十六烷基、n-十七烷基、n-十八烷基、n-十九烷基、n-二十烷基、環戊基、環己基、這些一種或複數種在碳原子數至20的範圍進行鍵結的基,與這些基之一的伸甲基或未相鄰的複數個伸甲基可取代為醚鍵的基等可作為一例子舉出。Examples of the alkyl group having 1 carbon atom are a methyl group, and specific examples of the alkyl group having 2 to 20 carbon atoms include ethyl, n-propyl, i-propyl, n-butyl, and i-butyl. S-butyl, t-butyl, n-pentyl, 1-methyl-n-butyl, 2-methyl-n-butyl, 3-methyl-n-butyl, 1,1 -Dimethyl-n-propyl, n-hexyl, 1-methyl-n-pentyl, 2-methyl-n-pentyl, 1,1-dimethyl-n-butyl, 1-ethyl -N-butyl, 1,1,2-trimethyl-n-propyl, n-heptyl, n-octyl, n-nonyl, n-decyl, n-undecyl, n -Dodecyl, n-tridecyl, n-tetradecyl, n-pentadecyl, n-hexadecyl, n-hexadecyl, n-octadecyl, n- Undecyl, n-icosyl, cyclopentyl, cyclohexyl, one or more of these groups are bonded in the range of carbon atoms to 20, and are methylated or unphased with one of these groups Examples of groups in which a plurality of ortho-methyl groups may be substituted with an ether bond are given as an example.

此等中,以碳原子數2至10的伸烷基為佳,R53 表示伸乙基,R54 表示伸己基由原料容易獲得等觀點來看為特佳。Among these, an alkylene group having 2 to 10 carbon atoms is preferred, R 53 represents an ethylene group, and R 54 represents an alkylene group which is easily available from a raw material.

作為R52 的定義中之碳原子數1至20的烷基之具體例子,可舉出R53 的定義中之碳原子數2至20的烷基之具體例子及甲基。此等中,以碳原子數1至6的烷基為佳,以甲基、乙基、n-丙基或n-丁基為特佳。Specific examples of the alkyl group having 1 to 20 carbon atoms in the definition of R 52 include specific examples of the alkyl group having 2 to 20 carbon atoms in the definition of R 53 and a methyl group. Among these, an alkyl group having 1 to 6 carbon atoms is preferable, and a methyl group, an ethyl group, an n-propyl group, or an n-butyl group is particularly preferable.

作為r,可舉出2以上9以下之自然數,其中亦以2至6者為佳。As r, a natural number of 2 to 9 is mentioned, and 2 to 6 is also preferable.

含有本發明之實施形態的硬化膜形成組成物中之(D)成分時的含有量對於(A)成分之聚合物100質量份而言,以1質量份~100質量份為佳,更佳為5質量份~70質量份。將(D)成分之含有量作為1質量份以上時,所形成的硬化膜可賦予充分的密著性。但若比100質量份多時,液晶配向性容易降低。The content of the component (D) in the cured film-forming composition according to the embodiment of the present invention is preferably 1 part by mass to 100 parts by mass, and more preferably 100 parts by mass of the polymer of the component (A). 5 parts by mass to 70 parts by mass. When the content of the component (D) is 1 part by mass or more, the formed cured film can provide sufficient adhesion. However, if it is more than 100 parts by mass, the alignment of the liquid crystal is liable to decrease.

又,對於本實施形態之硬化膜形成組成物,(D)成分可為(D)成分之化合物的複數種類之混合物。In the cured film-forming composition of the present embodiment, the component (D) may be a mixture of a plurality of types of compounds of the component (D).

<溶劑>   本發明之硬化膜形成組成物中,主要在溶解於溶劑之溶液狀態下使用。此時所使用的溶劑僅可溶解(A)成分及視必要的(B)成分、(C)成分、(D)成分及/或後述之其他添加劑即可,對於其種類及結構等並無特別限定。<Solvent> The hardened film forming composition of the present invention is mainly used in a solution state dissolved in a solvent. The solvent used at this time can only dissolve the component (A) and optionally (B) component, (C) component, (D) component and / or other additives described later, and there is no particular limitation on the type and structure thereof. limited.

作為溶劑之具體例子,例如可舉出甲醇、乙醇、n-丙醇、異丙醇、n-丁醇、異丁醇、2-甲基-1-丁醇、n-戊醇、乙二醇單甲基醚、乙二醇單乙基醚、甲基溶纖劑乙酸酯、乙基溶纖劑乙酸酯、二乙二醇、二乙二醇單甲基醚、二乙二醇單乙基醚、丙二醇、丙二醇單甲基醚、丙二醇單甲基醚乙酸酯、丙二醇單乙基醚、丙二醇丙基醚、丙二醇丙基醚乙酸酯、甲苯、二甲苯、甲基乙基酮、異丁基甲基酮、環戊酮、環己酮、2-丁酮、3-甲基-2-戊酮、2-戊酮、2-庚酮、γ-丁內酯、2-羥基丙酸乙酯、2-羥基-2-甲基丙酸乙酯、乙氧基乙酸乙酯、羥基乙酸乙酯、2-羥基-3-甲基丁烷酸甲酯、3-甲氧基丙酸甲酯、3-甲氧基丙酸乙酯、3-乙氧基丙酸甲酯、3-乙氧基丙酸乙酯、丙酮酸甲酯、丙酮酸乙酯、乙酸乙酯、乙酸丁酯、乳酸乙酯、乳酸丁酯、環戊基甲基醚、N,N-二甲基甲醯胺、N,N-二甲基乙醯胺,及N-甲基-2-吡咯啶酮等。Specific examples of the solvent include methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol, 2-methyl-1-butanol, n-pentanol, and ethylene glycol. Monomethyl ether, ethylene glycol monoethyl ether, methyl cellosolve acetate, ethyl cellosolve acetate, diethylene glycol, diethylene glycol monomethyl ether, diethylene glycol mono Ethyl ether, propylene glycol, propylene glycol monomethyl ether, propylene glycol monomethyl ether acetate, propylene glycol monoethyl ether, propylene glycol propyl ether, propylene glycol propyl ether acetate, toluene, xylene, methyl ethyl ketone , Isobutyl methyl ketone, cyclopentanone, cyclohexanone, 2-butanone, 3-methyl-2-pentanone, 2-pentanone, 2-heptanone, γ-butyrolactone, 2-hydroxypropionic acid Ethyl acetate, ethyl 2-hydroxy-2-methylpropanoate, ethyl ethoxyacetate, ethyl hydroxyacetate, methyl 2-hydroxy-3-methylbutanoate, methyl 3-methoxypropionate Esters, ethyl 3-methoxypropionate, methyl 3-ethoxypropionate, ethyl 3-ethoxypropionate, methyl pyruvate, ethyl pyruvate, ethyl acetate, butyl acetate, Ethyl lactate, butyl lactate, cyclopentyl methyl ether, N, N-dimethylformamide, N, N-dimethyl As acetamide, and N- methyl-2-pyrrolidone, and the like.

使用本發明之硬化膜形成組成物,於樹脂薄膜上形成硬化膜,製造配向材料時,由甲醇、乙醇、n-丙醇、異丙醇、n-丁醇、2-甲基-1-丁醇、2-庚酮、異丁基甲基酮、二乙二醇、丙二醇、丙二醇單甲基醚、環戊基甲基醚、丙二醇單甲基醚乙酸酯、乙酸乙酯、乙酸丁酯等為樹脂薄膜顯示耐性的溶劑之觀點來看為佳。The hardened film forming composition of the present invention is used to form a hardened film on a resin film. When manufacturing an alignment material, methanol, ethanol, n-propanol, isopropanol, n-butanol, and 2-methyl-1-butane are used. Alcohol, 2-heptanone, isobutyl methyl ketone, diethylene glycol, propylene glycol, propylene glycol monomethyl ether, cyclopentyl methyl ether, propylene glycol monomethyl ether acetate, ethyl acetate, butyl acetate, etc. are From the viewpoint of a solvent in which the resin film exhibits resistance, it is preferable.

這些溶劑可單獨使用1種或組合2種以上使用。These solvents can be used individually by 1 type or in combination of 2 or more types.

<其他添加劑>   且本發明之硬化膜形成組成物中不損害本發明之效果下,視必要可含有密著向上劑、矽烷偶合劑、界面活性劑、流變調整劑、顏料、染料、保存安定劑、消泡劑、抗氧化劑等。<Other additives> Without impairing the effect of the present invention in the cured film-forming composition of the present invention, it may contain an adhesion upward agent, a silane coupling agent, a surfactant, a rheology modifier, a pigment, a dye, and storage stability as necessary. Agents, defoamers, antioxidants, etc.

<硬化膜形成組成物之調製>   本發明之硬化膜形成組成物為含有(A)成分之聚合物,視必要可含有(B)成分的聚合物、(C)成分之交聯觸媒及(D)成分之密著促進劑,進一步不損害本發明之效果下,可含有其他添加劑之組成物。通常以將這些溶解於溶劑之溶液的形態下使用。<Preparation of hardened film-forming composition> 硬化 The hardened film-forming composition of the present invention is a polymer containing the component (A), and may optionally contain a polymer of the component (B), a crosslinking catalyst of the component (C), and ( D) The component adhesion promoter may further contain a composition containing other additives without impairing the effects of the present invention. These are usually used in the form of a solution dissolved in a solvent.

本發明之硬化膜形成組成物的較佳例子,如以下所示。   [1]:含有(A)成分之硬化膜形成組成物。   [2]:含有(A)成分、依據(A)成分100質量份之1~400質量份的(B)成分以及溶劑之硬化膜形成組成物。   [3]:含有(A)成分、依據(A)成分100質量份之1~400質量份的(B)成分、對於(A)成分之聚合物100質量份而言為0.01質量份~20質量份之(C)成分、溶劑的硬化膜形成組成物。   [4]:含有(A)成分、依據(A)成分100質量份之1~400質量份之(B)成分、對於(A)成分之聚合物100質量份而言為0.01質量份~20質量份之(C)成分、對於(A)成分之聚合物100質量份而言為1質量份~100質量份之(D)成分以及溶劑之硬化膜形成組成物。Preferred examples of the cured film-forming composition of the present invention are shown below. [1]: A cured film-forming composition containing the component (A). [2]: A hardened film-forming composition containing the component (A), the component (B) in an amount of 1 to 400 parts by mass based on 100 parts by mass of the component (A), and a solvent. [3]: The component (B) containing (A) component, 1 to 400 parts by mass based on 100 parts by mass of (A) component, and 0.01 to 20 parts by mass for 100 parts by mass of polymer of (A) component (C) component, a cured film forming composition of a solvent. [4]: (A) component, 1 to 400 parts by mass of (B) component based on 100 parts by mass of (A) component, 0.01 to 20 parts by mass for 100 parts by mass of polymer of (A) component The cured film forming composition of the component (C), the component (D) of 1 to 100 parts by mass with respect to 100 parts by mass of the polymer of the component (A), and the solvent.

將本發明之硬化膜形成組成物作為溶液使用時的配合比例、調製方法等如以下詳述。   本發明之硬化膜形成組成物中之固體成分的比例以可將各成分均勻地溶解於溶劑者即可,並無特別限定,但以1質量%~60質量%為佳,較佳為2質量%~50質量%,更佳為2質量%~20質量%。其中所謂固體成分表示自硬化膜形成組成物的全成分除去溶劑者。The compounding ratio and preparation method when the cured film-forming composition of the present invention is used as a solution will be described in detail below. The proportion of the solid content in the cured film-forming composition of the present invention is not particularly limited as long as it can dissolve each component uniformly in a solvent, but it is preferably 1% to 60% by mass, and more preferably 2% by mass. % To 50% by mass, and more preferably 2% to 20% by mass. Herein, the so-called solid content means that the solvent is removed from all the components of the cured film-forming composition.

本發明之硬化膜形成組成物的調製方法並無特別限定。作為調製法,例如於溶劑中溶解(A)成分之溶液中,視必要將(B)成分、(C)成分、(D)成分等以所定比例進行混合,成為均勻溶液之方法,或對於該調製法之適當階段,視必要可進一步添加其他添加劑而混合之方法可舉出。The method for preparing the cured film-forming composition of the present invention is not particularly limited. As a preparation method, for example, in a solution in which the component (A) is dissolved in a solvent, the components (B), (C), (D), etc. are mixed in a predetermined ratio as necessary to obtain a homogeneous solution. An appropriate stage of the preparation method is a method in which other additives can be further added and mixed as necessary.

對於本發明之硬化膜形成組成物的調製,藉由溶劑中之聚合反應所得之特定共聚物(聚合物)的溶液可直接使用。此時,例如於(A)成分之溶液中與前述同樣地,視必要加入(B)成分、(C)成分、(D)成分等後成為均勻溶液。此時,將濃度調整作為目的,可再追加投入溶劑。此時,在(A)成分之生成過程所使用的溶劑與使用於硬化膜形成組成物之濃度調整的溶劑可為相同或相異。For the preparation of the cured film-forming composition of the present invention, a solution of a specific copolymer (polymer) obtained by a polymerization reaction in a solvent can be used directly. At this time, for example, in the solution of the component (A), as described above, the components (B), (C), and (D) are added as necessary to obtain a uniform solution. In this case, for the purpose of concentration adjustment, an additional solvent may be added. At this time, the solvent used in the production process of the component (A) and the solvent used for the concentration adjustment of the cured film-forming composition may be the same or different.

又,所調製之硬化膜形成組成物的溶液可使用孔徑為0.2μm程度之濾器等進行過濾後使用為佳。The solution of the prepared hardened film-forming composition can be used after filtering using a filter having a pore size of about 0.2 μm or the like.

<硬化膜、配向材料及相位差材料>   將本發明之硬化膜形成組成物的溶液於基板(例如矽/二酸化矽被覆基板、氮化矽基板、金屬,例如鋁、鉬、鉻等包覆的基板、玻璃基板、石英基板、ITO基板等)或薄膜基板(例如三乙醯纖維素(TAC)薄膜、聚碳酸酯(PC)薄膜、環烯烴聚合物(COP)薄膜、環烯烴共聚物(COC)薄膜、聚乙烯對苯二甲酸乙二醇酯(PET)薄膜、丙烯酸薄膜、聚乙烯薄膜等樹脂薄膜)等上以棒塗布、轉動塗布、流動塗布、輥塗布、狹縫塗布、狹縫繼續以轉動塗布、噴墨塗布、印刷等進行塗布後形成塗膜,其後以加熱板或烤箱等進行加熱乾燥後,可形成硬化膜。該硬化膜可直接作為配向材料使用。<Hardened film, alignment material, and retardation material> The solution of the hardened film forming composition of the present invention is coated on a substrate (such as a silicon / diacid-coated substrate, a silicon nitride substrate, a metal, such as aluminum, molybdenum, chromium, etc. Substrate, glass substrate, quartz substrate, ITO substrate, etc.) or film substrate (e.g. triethyl cellulose (TAC) film, polycarbonate (PC) film, cyclic olefin polymer (COP) film, cyclic olefin copolymer (COC ) Film, resin film such as polyethylene terephthalate (PET) film, acrylic film, polyethylene film, etc.) Rod coating, spin coating, flow coating, roll coating, slit coating, slitting continue A coating film is formed after coating by spin coating, inkjet coating, printing, etc., and then a heating plate or an oven is used for drying to form a cured film. This hardened film can be used directly as an alignment material.

作為加熱乾燥之條件,僅將硬化膜(配向材料)的成分塗布於上面後不會溶離於聚合性液晶溶液之程度下可藉由交聯劑進行交聯反應者即可,例如在溫度60℃~200℃,時間為0.4分鐘~60分鐘之範圍中採用適宜地選擇之加熱溫度及加熱時間。加熱溫度及加熱時間較佳為70℃~160℃,0.5分鐘~10分鐘。As a condition for heating and drying, only a component of the cured film (alignment material) can be subjected to a cross-linking reaction with a cross-linking agent to the extent that it does not dissolve in the polymerizable liquid crystal solution after being coated on it, for example, at a temperature of 60 ° A heating temperature and a heating time appropriately selected are used in the range of -200 ° C and the time is 0.4 minutes to 60 minutes. The heating temperature and heating time are preferably 70 ° C to 160 ° C, and 0.5 minutes to 10 minutes.

使用本發明之硬化性組成物所形成的硬化膜(配向材料)之膜厚,例如0.05μm~5μm,可考慮到所使用之基板的段差或光學性、電性性質下適宜地選擇。The film thickness of the cured film (alignment material) formed using the curable composition of the present invention, for example, 0.05 μm to 5 μm, may be appropriately selected in consideration of the step difference, optical properties, and electrical properties of the substrate used.

欲使由本發明之硬化膜組成物所形成的配向材料具有耐溶劑性及耐熱性,於該配向材料上塗布具有垂直配向性之聚合性液晶溶液等相位差材料,可再配向材料上進行配向。而將成為配向狀態之相位差材料直接使其硬化後,可形成作為具有光學各向異性之層的相位差材料。而形成配向材料之基板為薄膜時,可作為相位差薄膜使用。In order to make the alignment material formed of the cured film composition of the present invention have solvent resistance and heat resistance, a phase difference material such as a polymerizable liquid crystal solution having vertical alignment is coated on the alignment material, and the alignment material can be aligned. When the phase difference material in the aligned state is directly hardened, a phase difference material as a layer having optical anisotropy can be formed. When the substrate forming the alignment material is a thin film, it can be used as a retardation film.

又,使用如上述所形成的具有本發明之配向材料的2片基板,介著間隔物,使兩基板上之配向材料成彼此面對面的方式貼合後,於這些基板之間注入液晶,液晶亦可作為經配向之液晶顯示元件。   如此本發明之硬化膜形成組成物可適用於各種相位差材料(相位差薄膜)或液晶顯示元件等製造上。 [實施例]In addition, after using the two substrates having the alignment material of the present invention formed as described above, the alignment materials on the two substrates are bonded to face each other via a spacer, and then liquid crystal is injected between these substrates. Can be used as an aligned liquid crystal display element. In this way, the cured film-forming composition of the present invention can be applied to the production of various retardation materials (phase retardation films), liquid crystal display elements, and the like. [Example]

以下舉出本發明之實施例,具體說明本發明,但本發明並非受限定於此等而解釋者。Examples of the present invention will be given below to specifically explain the present invention, but the present invention is not limited to these and is explained.

[在實施例使用的簡稱]   在以下實施例中所使用的簡稱的意思如以下所示。 <原料> CIN1CIN2CIN3CIN4GMA:縮水甘油基甲基丙烯酸酯   AIBN:α,α’-偶氮二異丁腈   BMAA:N-丁氧基甲基丙烯醯胺   HEMA:2-羥基乙基甲基丙烯酸酯   MMA:甲基甲基丙烯酸酯 <B成分>   HCM:下述結構式所示三聚氰胺交聯劑[Cymel(CYMEL)(註冊商標)303(Mitsui Cytec(股)製)]<C成分>   PTSA:p-甲苯磺酸・一水合物 <D成分>   D-1:具有下述結構式所示羥基及丙烯酸基之化合物D-2:具有下述結構式所示N-烷氧基甲基及丙烯酸基的化合物<溶劑>   實施例及比較例之各樹脂組成物為含有溶劑,作為該溶劑使用丙二醇單甲基醚(PM)、環己酮(CH)。[Abbreviations used in the examples] The meanings of abbreviations used in the following examples are as follows. < raw materials > CIN1 CIN2 CIN3 CIN4 GMA: glycidyl methacrylate AIBN: α, α'-azobisisobutyronitrile BMAA: N-butoxymethacrylamide HEMA: 2-hydroxyethyl methacrylate MMA: methylformyl Acrylate <B component> HCM: Melamine cross-linking agent represented by the following structural formula [Cymel (CYMEL) (registered trademark) 303 (Mitsui Cytec (stock))] <Component C> PTSA: p-Toluenesulfonic acid hydrazone monohydrate <Component D> D-1: Compound having a hydroxyl group and an acrylic group represented by the following structural formula D-2: Compound having N-alkoxymethyl and acrylic group represented by the following structural formula <Solvent> Each resin composition of an Example and a comparative example contains a solvent, and propylene glycol monomethyl ether (PM) and cyclohexanone (CH) are used as this solvent.

<聚合物的分子量之測定>   於聚合例中之丙烯酸共聚物的分子量為使用(股)Shodex公司製常溫凝膠滲透層析法(GPC)裝置(GPC-101)、Shodex公司製管柱(KD-803、KD-805)如以下所示進行測定。   且,下述數平均分子量(以下稱為Mn)及重量平均分子量(以下稱為Mw)係以聚苯乙烯換算值表示。   管柱溫度:40℃   溶離液:四氫呋喃   流速:1.0mL/分   標準曲線作成用標準試樣:昭和電工公司製 標準聚苯乙烯(分子量 約197,000、55,100、12,800、3,950、1,260、580)。<Measurement of Molecular Weight of Polymer> The molecular weight of the acrylic copolymer used in the polymerization examples is a room temperature gel permeation chromatography (GPC) device (GPC-101) manufactured by Shodex, and a column (KD) manufactured by Shodex. -803, KD-805) were measured as follows. The number average molecular weight (hereinafter referred to as Mn) and weight average molecular weight (hereinafter referred to as Mw) are expressed in terms of polystyrene. Column temperature: 40 ° C Dissolved liquid: tetrahydrofuran Flow rate: 1.0 mL / min 曲线 Standard curve preparation standard sample: Standard polystyrene manufactured by Showa Denko Corporation (molecular weight: approximately 197,000, 55, 100, 12,800, 3,950, 1,260,580).

<參考例1> CIN1之合成    依據特表2013-514449號公報所記載的合成方法,合成CIN1。<Reference Example 1> Synthesis of CIN1 CIN1 was synthesized according to the synthesis method described in Japanese Patent Application Publication No. 2013-514449.

<參考例2> CIN2之合成    混合GMA 8.3g(58.4mmol)、4-甲氧基桂皮酸 20.7g(116.2mmol)、二丁基羥基甲苯 0.2g、三苯基乙基鏻溴化物 0.3g、二噁烷 80mL,在90℃下加熱3天。反應終了後,將二噁烷減壓餾去後,加入乙酸乙酯 150mL,過濾分離不溶物後,加入碳酸氫鈉水100mL洗淨3次,除去過剩甲氧基桂皮酸。將乙酸乙酯進行減壓餾去後得到目的物之CIN2 16.5g(產率:88%)。<Reference Example 2> CIN2 synthesis mixed GMA 8.3g (58.4mmol), 4-methoxycinnamic acid 20.7g (116.2mmol), dibutylhydroxytoluene 0.2g, triphenylethylphosphonium bromide 0.3g, 80 mL of dioxane was heated at 90 ° C for 3 days. After the reaction was completed, dioxane was distilled off under reduced pressure, and 150 mL of ethyl acetate was added. After the insoluble matter was separated by filtration, 100 mL of sodium bicarbonate water was added and washed three times to remove excess methoxycinnamic acid. Ethyl acetate was distilled off under reduced pressure to obtain 16.5 g (yield: 88%) of the desired product CIN2.

<參考例3> CIN3之合成    依據國際公開手冊WO2013/191251所記載的合成方法,合成CIN3。<Reference Example 3> Synthesis of CIN3 CIN3 was synthesized according to the synthesis method described in International Publication WO2013 / 191251.

<參考例4> CIN4之合成    依據Macromolecules,39,9357-9364(2006)所記載的合成方法,合成CIN4。<Reference Example 4> Synthesis of CIN4 CIN4 was synthesized according to the synthesis method described in Macromolecules, 39,9357-9364 (2006).

<A成分之合成> <聚合例1>   將CIN1 15.0g、BMAA 1.7g、作為聚合觸媒的AIBN 0.4g溶解於PM 123.4g、CH 30.9g,於80℃進行20小時反應後,得到含有丙烯酸共聚物(PA-1)10重量%之溶液。所得之丙烯酸共聚物的Mn為10,000,Mw為29,000。<Synthesis of Component A> <Polymerization Example 1> Dissolved 15.0 g of CIN1, 1.7 g of BMAA, and 0.4 g of AIBN as a polymerization catalyst in 123.4 g of PM and 30.9 g of CH, and reacted at 80 ° C for 20 hours to obtain acrylic acid containing acrylic acid. 10% by weight solution of copolymer (PA-1). The obtained acrylic copolymer had Mn of 10,000 and Mw of 29,000.

<聚合例2>   將CIN2 15.0g、BMAA 1.7g、作為聚合觸媒的AIBN 0.5g溶解於PM 155.9g,於80℃進行20小時反應後,得到含有丙烯酸共聚物(PA-2)10重量%之溶液。所得之丙烯酸共聚物的Mn為8,400,Mw為18,000。<Polymerization Example 2> 15.0 g of CIN2, 1.7 g of BMAA, and 0.5 g of AIBN as a polymerization catalyst were dissolved in 155.9 g of PM and reacted at 80 ° C for 20 hours to obtain 10% by weight of an acrylic copolymer (PA-2). Its solution. The obtained acrylic copolymer had a Mn of 8,400 and a Mw of 18,000.

<聚合例3>   將CIN3 15.0g、BMAA 1.4g、作為聚合觸媒的AIBN 0.4g溶解於PM 120.3g、CH 30.1g,於80℃進行20小時反應後,得到含有丙烯酸共聚物(PA-3)10重量%之溶液。所得之丙烯酸共聚物的Mn為18,000,Mw為55,000。<Polymerization Example 3> Dissolved 15.0 g of CIN3, 1.4 g of BMAA, and 0.4 g of AIBN as a polymerization catalyst in 120.3 g of PM and 30.1 g of CH, and reacted at 80 ° C for 20 hours to obtain an acrylic copolymer (PA-3 ) 10% by weight solution. The obtained acrylic copolymer had a Mn of 18,000 and a Mw of 55,000.

<聚合例4>   將CIN4 15.0g、BMAA 1.8g、作為聚合觸媒的AIBN 0.9g溶解於PM 111.5g、CH 47.8g,於80℃進行20小時反應後,得到含有丙烯酸共聚物(PA-4)10重量%之溶液。所得之丙烯酸共聚物的Mn為9,000,Mw為20,000。<Polymerization Example 4> 溶解 Dissolved 15.0 g of CIN4, 1.8 g of BMAA, and 0.9 g of AIBN as a polymerization catalyst in 111.5 g of PM and 47.8 g of CH, and reacted at 80 ° C for 20 hours to obtain an acrylic copolymer (PA-4). ) 10% by weight solution. The obtained acrylic copolymer had a Mn of 9,000 and a Mw of 20,000.

<聚合例5>   將CIN3 10.0g、BMAA 3.0g、作為聚合觸媒的AIBN 0.4g溶解於PM 96.6g、CH 24.2g,於80℃進行20小時反應後,得到含有丙烯酸共聚物(PA-5)10重量%之溶液。所得之丙烯酸共聚物的Mn為8,000,Mw為20,000。<Polymerization Example 5> 溶解 10.0 g of CIN3, 3.0 g of BMAA, and 0.4 g of AIBN as a polymerization catalyst were dissolved in 96.6 g of PM and 24.2 g of CH, and reacted at 80 ° C for 20 hours to obtain an acrylic copolymer (PA-5 ) 10% by weight solution. The obtained acrylic copolymer had Mn of 8,000 and Mw of 20,000.

<聚合例6>   將CIN3 15.0g、BMAA 0.9g、HEMA 0.7g、作為聚合觸媒的AIBN 0.4g溶解於PM 122.4g、CH 30.6g,於80℃進行20小時反應後,得到含有丙烯酸共聚物(PA-6)10重量%之溶液。所得之丙烯酸共聚物的Mn為11,000,Mw為32,000。<Polymerization Example 6> Dissolved 15.0 g of CIN3, 0.9 g of BMAA, 0.7 g of HEMA, and 0.4 g of AIBN as a polymerization catalyst in 122.4 g of PM and 30.6 g of CH, and reacted at 80 ° C for 20 hours to obtain an acrylic copolymer. (PA-6) 10% by weight solution. The obtained acrylic copolymer had Mn of 11,000 and Mw of 32,000.

<聚合例7>   將CIN3 15.0g、HEMA 1.2g、作為聚合觸媒的AIBN 0.4g溶解於PM 118.4g、CH 29.6g,於80℃進行20小時反應後,得到含有丙烯酸共聚物(PA-7)10重量%之溶液。所得之丙烯酸共聚物的Mn為10,000,Mw為35,000。<Polymerization Example 7> Dissolved 15.0 g of CIN3, 1.2 g of HEMA, and 0.4 g of AIBN as a polymerization catalyst in 118.4 g of PM and 29.6 g of CH, and reacted at 80 ° C for 20 hours to obtain an acrylic copolymer (PA-7). ) 10% by weight solution. The obtained acrylic copolymer had Mn of 10,000 and Mw of 35,000.

<聚合例8>   將CIN2 15.0g、HEMA 1.5g、作為聚合觸媒的AIBN 0.5g溶解於PM 122.4g、CH 30.6g,於80℃進行20小時反應後,得到含有丙烯酸共聚物(PA-8)10重量%之溶液。所得之丙烯酸共聚物的Mn為8,700,Mw為28,000。<Polymerization Example 8> 15.0g of CIN2, 1.5g of HEMA, and 0.5g of AIBN as a polymerization catalyst were dissolved in 122.4g of PM and 30.6g of CH, and reacted at 80 ° C for 20 hours to obtain an acrylic copolymer (PA-8 ) 10% by weight solution. The obtained acrylic copolymer had a Mn of 8,700 and a Mw of 28,000.

<B成分之合成> <聚合例9>   將BMAA 100.0g、作為聚合觸媒的AIBN 4.2g溶解於PM 193.5g,於90℃進行20小時反應後,得到丙烯酸聚合物溶液。所得之丙烯酸聚合物的Mn為2,700,Mw為3,900。將丙烯酸聚合物溶液徐徐滴入己烷2000.0g後析出固體,藉由過濾及減壓乾燥後得到聚合物(PB-1)。<Synthesis of Component B> <Polymerization Example 9> (100.0 g of BMAA and 4.2 g of AIBN as a polymerization catalyst were dissolved in 193.5 g of PM and reacted at 90 ° C for 20 hours to obtain an acrylic polymer solution. The obtained acrylic polymer had an Mn of 2,700 and an Mw of 3,900. The acrylic polymer solution was slowly dropped into 2000.0 g of hexane, and a solid was precipitated. The polymer (PB-1) was obtained by filtration and drying under reduced pressure.

<聚合例10>   將MMA 30.0g、HEMA 3.0g、作為聚合觸媒的AIBN 0.3g溶解於PM 146.0g,於80℃進行20小時反應後,得到丙烯酸共聚物溶液。將丙烯酸共聚物溶液徐徐滴入於己烷1000.0g後析出固體,藉由過濾及減壓乾燥後得到丙烯酸共聚物(PB-2)。所得之丙烯酸共聚物的Mn為18,000,Mw為32,800。<Polymerization Example 10> 3 30.0 g of MMA, 3.0 g of HEMA, and 0.3 g of AIBN as a polymerization catalyst were dissolved in 146.0 g of PM and reacted at 80 ° C for 20 hours to obtain an acrylic copolymer solution. The acrylic copolymer solution was gradually dropped into 1000.0 g of hexane, and a solid was precipitated. The acrylic copolymer (PB-2) was obtained by filtration and drying under reduced pressure. The obtained acrylic copolymer had a Mn of 18,000 and a Mw of 32,800.

<聚合性液晶溶液之調製>   加入聚合性液晶LC242(BASF公司製)29.0g、作為聚合起始劑的IRGACURE907(BASF公司製)0.9g、作為塗平劑之BYK-361N(BYK公司製)0.2g、作為溶劑的環戊酮,得到固體成分濃度為30質量%之聚合性液晶溶液(RM-1)。<Preparation of polymerizable liquid crystal solution> Add 29.0 g of polymerizable liquid crystal LC242 (manufactured by BASF), 0.9 g of IRGACURE907 (manufactured by BASF) as a polymerization initiator, and BYK-361N (manufactured by BYK) 0.2 as a leveling agent. g. Cyclopentanone as a solvent to obtain a polymerizable liquid crystal solution (RM-1) having a solid content concentration of 30% by mass.

<實施例1>   含有上述聚合例1所得之丙烯酸共聚物(PA-1)的溶液以丙烯酸共聚物(PA-1)換算而相當於100質量份之量,與p-甲苯磺酸・一水合物 5質量份,於此加入PM及CH,溶劑組成為PM:CH=80:20(質量比),固體成分濃度為5.0質量%之溶液。將該溶液以孔徑1μm的濾器進行過濾後,調製出液晶配向劑用組成物A-1。 <實施例2至10及比較例1至3>   將A成分之丙烯酸共聚物,以及其他成分之種類及量各如表1所記載以外,實施與實施例1之相同步驟,各調製出液晶配向劑用組成物A-2至A-13。<Example 1> A solution containing the acrylic copolymer (PA-1) obtained in the above polymerization example 1 was equivalent to 100 parts by mass in terms of acrylic copolymer (PA-1), and was monohydrated with p-toluenesulfonic acid hydrazone. 5 parts by mass of the product, PM and CH were added here, and the solvent composition was a solution of PM: CH = 80: 20 (mass ratio) and a solid content concentration of 5.0% by mass. This solution was filtered through a filter having a pore size of 1 μm, and then a composition A-1 for a liquid crystal alignment agent was prepared. <Examples 2 to 10 and Comparative Examples 1 to 3> The types and amounts of the acrylic copolymer of component A, and other components were as described in Table 1, and the same steps as in Example 1 were performed to prepare liquid crystal alignments. Compositions A-2 to A-13.

<實施例11至20及比較例4至6> [配向性之評估]   將實施例1至10及比較例1至3之各配向劑用組成物,使用棒塗布塗布於TAC薄膜上至Wet膜厚4μm。各在溫度110℃下進行120秒的在熱循環式烤箱中之加熱乾燥,於TAC薄膜上形成各硬化膜。於該各硬化膜上將313nm的直線偏光以20mJ/cm2 的曝光量以垂直方向照射,形成配向材料。於TAC薄膜上之配向材料上面,使用棒塗布塗布聚合性液晶溶液(RM-1)至Wet膜厚6μm。將該塗膜在溫度90℃之加熱板上進行60秒乾燥後,以300mJ/cm2 進行曝光,製作出相位差材料。將所製作的基板上之相位差材料以一對偏光板夾住,觀察於相位差材料中之相位差特性的表現狀況,相位差無表現缺陷者評估為○,未表現相位差者評估為×,而記載於「配向性」之欄上。評估結果歸納於後述的表2。<Examples 11 to 20 and Comparative Examples 4 to 6> [Evaluation of Orientation] The compositions for each of the alignment agents of Examples 1 to 10 and Comparative Examples 1 to 3 were applied on a TAC film to a Wet film using a rod coating 4 μm thick. Each was heated and dried in a thermal cycle oven at a temperature of 110 ° C. for 120 seconds to form each cured film on the TAC film. On each of the cured films, linearly polarized light of 313 nm was irradiated in a vertical direction at an exposure amount of 20 mJ / cm 2 to form an alignment material. On the alignment material on the TAC film, a polymerizable liquid crystal solution (RM-1) was applied with a rod coating to a Wet film thickness of 6 μm. This coating film was dried on a hot plate at a temperature of 90 ° C. for 60 seconds, and then exposed at 300 mJ / cm 2 to produce a retardation material. The phase difference material on the produced substrate was sandwiched by a pair of polarizing plates, and the performance of the phase difference characteristics in the phase difference material was observed. Those who did not show defects in the phase difference were evaluated as ○, and those who did not show phase difference were evaluated as × , And recorded in the column of "alignment". The evaluation results are summarized in Table 2 described later.

如表2所示,在實施例11至20所得之相位差材料顯示良好配向性。相對於此,在比較例4至6所得之相位差材料未得到良好配向性。 [產業上可利用性]As shown in Table 2, the retardation materials obtained in Examples 11 to 20 showed good alignment. In contrast, the phase difference materials obtained in Comparative Examples 4 to 6 did not obtain good alignment. [Industrial availability]

由本發明所得之硬化膜形成組成物為,作為形成液晶顯示元件之液晶配向膜,或欲形成設置於液晶顯示元件之內部或外部的光學各向異性薄膜時的配向材料的材料上非常有用,特別作為IPS-LCD或有機EL顯示器的反射防止膜使用之圓偏光板的以相位差材料為主的材料上為適當。The cured film-forming composition obtained by the present invention is very useful as a material for forming a liquid crystal alignment film for a liquid crystal display element, or as an alignment material when an optically anisotropic film is provided inside or outside the liquid crystal display element, and is particularly useful. The circularly polarizing plate used as an anti-reflection film of an IPS-LCD or an organic EL display is preferably a material mainly composed of a retardation material.

Claims (11)

一種硬化膜形成組成物,其特徵為含有具有(A)光二聚化部位及自身交聯部位的聚合物。A cured film-forming composition comprising a polymer having (A) a photodimerization site and a self-crosslinking site. 如請求項1之硬化膜形成組成物,其中(A)成分的自身交聯部位為羥甲基或烷氧基甲基。The cured film-forming composition according to claim 1, wherein the self-crosslinking site of the component (A) is methylol or alkoxymethyl. 如請求項1或2之硬化膜形成組成物,其中進一步含有(B)具有2個以上選自由羥甲基、烷氧基甲基、羥基、羧基、醯胺基、胺基及烷氧基矽基所成群的至少1個基之單體或者聚合物。The hardened film-forming composition according to claim 1 or 2, further comprising (B) two or more selected from the group consisting of methylol, alkoxymethyl, hydroxyl, carboxyl, amido, amino, and alkoxysilyl A monomer or polymer having at least one group in which the groups are grouped. 如請求項1至3中任一項之硬化膜形成組成物,其中進一步含有(C)交聯觸媒。The cured film-forming composition according to any one of claims 1 to 3, further comprising (C) a crosslinking catalyst. 如請求項1至4中任一項之硬化膜形成組成物,其中進一步含有(D)具有1個以上的聚合性基與選自由羥基、羧基、醯胺基、胺基及烷氧基矽基所成群的至少1個基A,或與該基A進行反應的至少1個基的化合物。The hardened film-forming composition according to any one of claims 1 to 4, further comprising (D) one or more polymerizable groups and a member selected from the group consisting of a hydroxyl group, a carboxyl group, a amine group, an amine group, and an alkoxysilyl group. Compounds of at least one group A or at least one group that react with the group A. 如請求項3至5中任一項之硬化膜形成組成物,其中對於(A)成分的100質量份而言,含有1質量份至400質量份的(B)成分。The cured film-forming composition according to any one of claims 3 to 5, wherein 100 parts by mass of the (A) component contains 1 to 400 parts by mass of the (B) component. 如請求項4至6中任一項之硬化膜形成組成物,其中對於(A)成分的100質量份而言,含有0.01質量份至20質量份的(C)成分。The cured film-forming composition according to any one of claims 4 to 6, which contains 0.01 to 20 parts by mass of the (C) component for 100 parts by mass of the (A) component. 如請求項5至7中任一項之硬化膜形成組成物,其中對於(A)成分的100質量份而言,含有1質量份至100質量份的(D)成分。The cured film-forming composition according to any one of claims 5 to 7, wherein 100 parts by mass of the (A) component contains 1 to 100 parts by mass of the (D) component. 一種硬化膜,其特徵為硬化如請求項1至8中任一項之硬化膜形成組成物而得者。A cured film obtained by curing the cured film-forming composition according to any one of claims 1 to 8. 一種配向材料,其特徵為硬化如請求項1至8中任一項之硬化膜形成組成物而得者。An alignment material characterized by being obtained by hardening the hardened film-forming composition according to any one of claims 1 to 8. 一種相位差材料,其特徵為使用由如請求項1至8中任一項之硬化膜形成組成物所得之硬化膜而形成者。A retardation material characterized by being formed using a cured film obtained from the cured film-forming composition according to any one of claims 1 to 8.
TW107110508A 2017-03-27 2018-03-27 Cured film formation composition, orientation material and retardation material TWI850195B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017-061705 2017-03-27
JP2017061705 2017-03-27

Publications (2)

Publication Number Publication Date
TW201900772A true TW201900772A (en) 2019-01-01
TWI850195B TWI850195B (en) 2024-08-01

Family

ID=63676390

Family Applications (1)

Application Number Title Priority Date Filing Date
TW107110508A TWI850195B (en) 2017-03-27 2018-03-27 Cured film formation composition, orientation material and retardation material

Country Status (5)

Country Link
JP (2) JP7260853B2 (en)
KR (1) KR102635863B1 (en)
CN (1) CN110461965A (en)
TW (1) TWI850195B (en)
WO (1) WO2018181364A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11367124B2 (en) 2019-10-25 2022-06-21 7-Eleven, Inc. Detecting and identifying misplaced items using a sensor array
US10621444B1 (en) 2019-10-25 2020-04-14 7-Eleven, Inc. Action detection during image tracking
US11176686B2 (en) 2019-10-25 2021-11-16 7-Eleven, Inc. Image-based action detection using contour dilation
CA3165141A1 (en) * 2019-10-25 2021-04-29 Sailesh Bharathwaaj Krishnamurthy Action detection during image tracking
JP7702120B2 (en) * 2020-09-17 2025-07-03 国立研究開発法人産業技術総合研究所 Photo- or thermo-responsive cleavable molecular layer
WO2022059590A1 (en) * 2020-09-17 2022-03-24 国立研究開発法人産業技術総合研究所 Light- or heat-responsive cleavage molecular layer
US20240182617A1 (en) * 2021-03-30 2024-06-06 Tosoh Corporation Fluorine resin, composition, photocrosslinked product, and electronic device provided therewith
WO2025047888A1 (en) * 2023-08-29 2025-03-06 日産化学株式会社 Composition for forming cured film, alignment material, and phase difference material

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55165858A (en) 1979-06-13 1980-12-24 Toppan Printing Co Ltd Center-bound bookbinding folding pagination and its processing method
JPH04207430A (en) 1990-11-30 1992-07-29 Nec Corp Multiple address file transfer system
JPH1068816A (en) 1996-08-29 1998-03-10 Sharp Corp Phase difference plate and circularly polarizing plate
EP1021479B1 (en) 1997-09-25 2002-07-17 Rolic AG Photocrosslinkable polyimides
JP2005049865A (en) 2003-07-17 2005-02-24 Arisawa Mfg Co Ltd Manufacturing method of optical retardation element
WO2008119426A1 (en) 2007-03-30 2008-10-09 Merck Patent Gmbh Birefingent layer with negative optical dispersion
JP5316740B2 (en) 2007-08-30 2013-10-16 Jsr株式会社 Method for forming liquid crystal alignment film
JP5373293B2 (en) 2008-01-29 2013-12-18 富士フイルム株式会社 Compound, liquid crystal composition and anisotropic material
JP5748061B2 (en) * 2009-07-21 2015-07-15 日産化学工業株式会社 Thermosetting film forming composition having photo-alignment property
ES2688658T3 (en) 2009-07-24 2018-11-06 Teikoku Seiyaku Co., Ltd. Adhesive preparation containing fentanyl for external use
US9102847B2 (en) * 2010-04-08 2015-08-11 Nissan Chemical Industries, Ltd. Composition for forming thermoset film having photo-alignment properties
WO2013054784A1 (en) * 2011-10-11 2013-04-18 日産化学工業株式会社 Cured film formation composition, orientation material, and phase difference material
KR102042441B1 (en) 2012-06-20 2019-11-08 닛산 가가쿠 가부시키가이샤 Novel polymerizable compound and method for producing same
KR102119632B1 (en) * 2012-07-12 2020-06-05 닛산 가가쿠 가부시키가이샤 Composition for forming cured film, alignment material, and phase difference material
JP6260790B2 (en) * 2012-09-12 2018-01-17 日産化学工業株式会社 Alignment material manufacturing method, alignment material, retardation material manufacturing method, and retardation material
KR102182361B1 (en) * 2012-12-27 2020-11-24 닛산 가가쿠 가부시키가이샤 Composition for forming cured film, orientation material, and phase difference material
JP6458949B2 (en) * 2013-04-16 2019-01-30 日産化学株式会社 Cured film forming composition, alignment material and retardation material
KR102333902B1 (en) * 2013-10-17 2021-12-02 닛산 가가쿠 가부시키가이샤 Composition for forming cured film, alignment material, and retardation material
KR102214086B1 (en) * 2014-02-13 2021-02-09 다이니폰 인사츠 가부시키가이샤 Thermosetting composition having photoalignment properties, alignment layer, substrate with alignment layer, phase difference plate, and device
KR102214075B1 (en) * 2014-02-13 2021-02-09 다이니폰 인사츠 가부시키가이샤 Thermosetting composition having photo-alignment properties, alignment layer, substrate with alignment layer, phase difference plate, and device
JP2015152744A (en) 2014-02-13 2015-08-24 大日本印刷株式会社 Thermosetting composition having photo-aligning property, alignment layer, substrate with alignment layer, retardation plate, and device
JP6519151B2 (en) 2014-11-18 2019-05-29 大日本印刷株式会社 Thermosetting composition having photoalignment, alignment layer, substrate with alignment layer and retardation plate
KR102339084B1 (en) * 2014-02-28 2021-12-14 닛산 가가쿠 가부시키가이샤 Cured-film-forming composition, alignment material, and phase difference material
US10081693B2 (en) 2014-02-28 2018-09-25 Nissan Chemical Industries, Ltd. Retardation material-forming resin composition, orientation material, and retardation material
JP6369146B2 (en) 2014-06-06 2018-08-08 大日本印刷株式会社 Thermosetting composition having photo-alignment, alignment layer, substrate with alignment layer, retardation plate and device
JP6604483B2 (en) * 2014-06-30 2019-11-13 日産化学株式会社 Cured film forming composition, alignment material and retardation material
JP6451248B2 (en) 2014-11-18 2019-01-16 大日本印刷株式会社 LAMINATE FOR TRANSFER, OPTICAL ELEMENT, AND METHOD FOR PRODUCING OPTICAL ELEMENT
JP2016098251A (en) * 2014-11-18 2016-05-30 大日本印刷株式会社 Thermosetting composition having photo-aligning property, method for manufacturing substrate with alignment layer, and method for manufacturing retardation plate
KR102570023B1 (en) * 2015-02-10 2023-08-23 닛산 가가쿠 가부시키가이샤 Cured-film-forming composition, alignment material, and phase difference material
CN107406720B (en) * 2015-03-11 2020-03-06 日产化学工业株式会社 Cured film forming composition, alignment material, and retardation material
JP6703295B2 (en) * 2015-05-28 2020-06-03 日産化学株式会社 Water-solvent liquid crystal aligning agent, liquid crystal aligning film and retardation material

Also Published As

Publication number Publication date
JPWO2018181364A1 (en) 2020-02-06
WO2018181364A1 (en) 2018-10-04
KR102635863B1 (en) 2024-02-13
TWI850195B (en) 2024-08-01
KR20190130583A (en) 2019-11-22
JP2023052367A (en) 2023-04-11
JP7260853B2 (en) 2023-04-19
CN110461965A (en) 2019-11-15

Similar Documents

Publication Publication Date Title
TWI850195B (en) Cured film formation composition, orientation material and retardation material
CN110256630B (en) Resin composition for forming phase difference material, alignment material, and phase difference material
JP6823295B2 (en) Polymers containing repeating units with N-alkoxymethyl groups and repeating units with side chains containing polymerizable C = C double bonds
TWI673290B (en) Cured film forming composition, alignment material and retardation material
KR102333902B1 (en) Composition for forming cured film, alignment material, and retardation material
CN104487510A (en) Cured film-forming composition, orientation material, and retardation material
TWI794261B (en) Cured film forming composition, alignment material and retardation material
TW201900705A (en) Hardened film forming composition, alignment material, and phase difference material
TWI865663B (en) Cured film forming composition, orientation material and phase difference material
TWI822746B (en) Cured film forming composition, alignment material and retardation material